Hospital-based Clinical Subjects - Publications

---

Hospital-based Clinical Subjects RDF, 13.8mb <RDF Zip, 1.2mb>
People, 1.3mb	Publications, 6.1mb	Groups, 53kb	Institutions, 28kb

BOTTOM

• 11601 Publication References

Author	Title	Date	Place of Publication	Research Group	Co-Authors
Webster N.R.	Increased mortality associated with growth hormone treatment in critically ill adults.	1999	University of Aberdeen	Anaesthesia and Intensive Care	Takala, J. Ruokenen, E. Nielsen, M.S.
Webster N.R.	The effects of intravenous antioxidants in patients with septic shock.	1997	University of Aberdeen	Anaesthesia and Intensive Care	Galley, H.F. Howdle, P.D. Walker, B.E.
Webster N.R.	Xanthine oxidase activity and free radical generation in patients with sepsis syndrome.	1996	University of Aberdeen	Anaesthesia and Intensive Care	Galley, H.F. Davies, M.J.
Webster N.R.	Increased nuclear factor k B activation in critically ill patients who die.	2000	University of Aberdeen	Anaesthesia and Intensive Care	Paterson, R.L. Galley, H.F. Dhillon, J.K.
Galley H.F.	Effect of the nitric oxide inhibitor, L-NG-monomethylarginine on accumulation of interleukin-6 and interleukin-8, and nuclear factor k B activity in a human endothelial cell line.	1999	University of Aberdeen	Anaesthesia and Intensive Care	Dhillon, J.K. Nelson, S.J. Webster. N.R.
Galley H.F.	Spinal but not general anesthesia increases the ratio of T helper 1 to T helper 2 cell subsets in patients undergoing transurethral resection of the prostate.	1998	University of Aberdeen	Anaesthesia and Intensive Care	Le Cras, A.E. Webster. N.R.
Galley H.F.	The effect of nitric oxide and peroxynitrite on apoptosis in human polymorphonuclear leukocytes.	1998	University of Aberdeen	Anaesthesia and Intensive Care	Blaylock, M.G. Cuthbertson, B.H. Webster, N.R
Galley H.F.	The effects of intravenous antioxidants in patients with septic shock.	1997	University of Aberdeen	Anaesthesia and Intensive Care	Howdle, P.D. Walker, B.E. Webster, N.R
YOUNG JD	Sound transmission between 50 and 600 Hz in excised pig lungs filled with air and helium	2000	University of Oxford	Anaesthetics	A. Leung S. Sehati C. McLeod
YOUNG JD	L-Arginine augments nitric oxide production and mesenteric blood flow in ovine endotoxemia	1996	University of Oxford	Anaesthetics	K.G. Allman A.P. Stoddart M.M. Kennedy
YOUNG JD	Effect of l-lysine on nitric oxide production in ovine endotoxaemia	1998	University of Oxford	Anaesthetics	K.G. Allman A.P. Stoddart
YOUNG JD	Delivery and monitoring of inhaled nitric oxide	1996	University of Oxford	Anaesthetics	O.J. Dyar
WIFFEN P	Anticonvulsant drugs for acute and chronic pain (Cochrane Review)	2000	University of Oxford	Anaesthetics	S.L. Collins H.J. McQuay D. Carroll
WIFFEN P	Single dose oral iboprofen and diclofenac for postoperative pain (Cochrane Review)	2000	University of Oxford	Anaesthetics	S.L. Collins R.A. Moore H.J. McQuay
WIFFEN P	An evidence base for WHO Essential analgesics	2000	University of Oxford	Anaesthetics
WHITELEY JP	The effect of inspired oxygen concentration on the ventilation-perfusion distribution in inhomogeneous lungs	2000	University of Oxford	Anaesthetics	D.J. Gavaghan C.E.W. Hahn
WHITELEY JP	A tidal breathing model of the inert gas sinewave technique for inhomogeneous lungs	2000	University of Oxford	Anaesthetics	D.J. Gavaghan C.E.W. Hahn
WHITELEY JP	The effect of the width of the ventilation-perfusion distribution on arterial blood content	1999	University of Oxford	Anaesthetics	D.J. Gavaghan C.E.W. Hahn
WHITELEY JP	A mathematical evaluation of the Multiple Breath Nitrogen Washout (MBNW) technique and the Multiple Inert Gas Elimination Technique (MIGET)	1998	University of Oxford	Anaesthetics	D.J. Gavaghan C.E.W. Hahn
SEAR JW	Effect of chronic intercurrent medication with b-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia	2000	University of Oxford	Anaesthetics	P. Foex S.J. Howell
SEAR JW	Intravenous anaesthetics: the alternative to gases	1998	University of Oxford	Anaesthetics
SEAR JW	Recent advances and developments in the clinical use of i.v. opiates during the peroperative period	1998	University of Oxford	Anaesthetics
SEAR JW	Risk factors for cardiovascular death following elective surgery under general anaesthesia	1998	University of Oxford	Anaesthetics	S.J. Howell Y.M. Sear D. Yeates
PIGOTT DW	Jarvick 2000 heart: potential for bridge to myocyte recovery	1998	University of Oxford	Anaesthetics	S. Westaby T. Katsumata R. Houel
PIGOTT DW	Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements	1999	University of Oxford	Anaesthetics	C. Nagle K.G. Allman S. Westaby
PIGOTT DW	Beneficial effect of concomitant administration of isoflurane and nicorandil	1997	University of Oxford	Anaesthetics	V. Piriou S. Ross R.D. Evans
PIGOTT DW	Mechanical bridge to recovery in fulfilment myocarditis	2000	University of Oxford	Anaesthetics	S. Westaby T. Katsumata X.Y. Jin
PANDIT JJ	Effects of subanaestetic sevoflurane on ventilation. 1. The response to acute and sustained hypercapnia	1999	University of Oxford	Anaesthetics	J. Manning Fox K.L. Dorrington P.A. Robbins
PANDIT JJ	Effects of subanaesthetic sevoflurane on ventilation. 2. The response to acute and sustained hypoxia in humans	1999	University of Oxford	Anaesthetics	J. Manning-Fox K.K. Dorrington P.A. Robbins
PANDIT JJ	Chemoreflex effects of low dose sevoflurane in humans	1998	University of Oxford	Anaesthetics	J. Manning-Fox K.K. Dorrington P.A. Robbins
PANDIT JJ	The statistical properties of breath-to-breath variations in ventilation at constant PETO2 and PETCO2	1996	University of Oxford	Anaesthetics	P.J. Liang P.A. Robbins
Murray JM	Intravenous lidocaine does not attenuate the cardiovascular and catecholamine response to a rapid increase in desflurane concentration	1996	The Queen's University of Belfast	Anaesthetics	Gormley WP Trinick TR
Murray JM	A qualitative investigation into the physical stability of polypropylene and polyethylene in liquid isoflurane and sevoflurane	2000	The Queen's University of Belfast	Anaesthetics	Renfrew CW Fee JPH
Murray JM	Serum glutathione S-transferase concentrations and creatinine clearance after sevoflurane anaesthesia	1997	The Queen's University of Belfast	Anaesthetics	Darling JR McBride DR Trinick TR
Murray JM	Amsorb - a new carbon dioxide absorbent for use in anesthetic breathing systems	1999	The Queen's University of Belfast	Anaesthetics	Renfrew CW Bedi A McCrystal CB
Mirakhur RK	Bolus dose remifentanil for control of haemodynamic response to tracheal intubation during rapid sequence induction of anaesthesia	1999	The Queen's University of Belfast	Anaesthetics	O'Hare R McAtamney D Hughes D
Mirakhur RK	Pharmacokinetics of rocuronium after bolus and continuous infusion during halothane anaesthesia	1996	The Queen's University of Belfast	Anaesthetics	McCoy EP Maddineni VR Wierda JMKH
Mirakhur RK	Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia	1998	The Queen's University of Belfast	Anaesthetics	Lowry DW McCarthy GJ Carroll MT
Mirakhur RK	Severe cardiovascular depression with remifentanil	2000	The Queen's University of Belfast	Anaesthetics	Elliott P O'Hare R Bill KM
McMurray TJ	Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery	2000	The Queen's University of Belfast	Anaesthetics	Gormley SMC McBride WT Armstrong MA
McMurray TJ	Tumour necrosis factor as predictor for pulmonary dysfunction after cardiac surgery	1998	The Queen's University of Belfast	Anaesthetics	Gilliland HE Armstrong MA
McMurray TJ	The inflammatory response to pediatric cardiac surgery: correlation of granulocyte adhesion molecule expression with postoperative oxygenation	1999	The Queen's University of Belfast	Anaesthetics	Gilliland HE Armstrong MA
McMurray TJ	The choice of anesthetic maintenance technique influences the antiinflammatory cytokine response to abdominal surgery	1997	The Queen's University of Belfast	Anaesthetics	Gilliland HE Armstrong MA Carabine U
MOORE RA	Reporting of adverse effects in clinical trials should be improved. Lessons from acute postoperative pain	1999	University of Oxford	Anaesthetics	J.E. Edwards H.J. McQuay S.L. Collins
MOORE RA	Bandolier: an evidence-based internet resource	2000	University of Oxford	Anaesthetics	Henry J. McQuay
MOORE RA	Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects	1998	University of Oxford	Anaesthetics	D.J. Gavaghan M.R. Tramer S.L. Collins
MOORE RA	Assessing the quality of reports of randomized clinical trials: is blinding necessary	1996	University of Oxford	Anaesthetics	A.R. Jadad D. Carroll C. Jenkinson
MCQUAY HJ	Impact of covert duplicate publication on meta-analysis: a case study	1997	University of Oxford	Anaesthetics	M.R. Tramer D.J.M. Reynolds R.A. Moore
MCQUAY HJ	Quantitative estimation of rare adverse events whiclh follow a biological progression - a new model applied to chronic NSAID use	2000	University of Oxford	Anaesthetics	M.R. Tramer R.A. Moore D.J.M. Reynolds
MCQUAY HJ	Opioids in pain management	1999	University of Oxford	Anaesthetics
MCQUAY HJ	An evidence-based resource for pain relief	1998	University of Oxford	Anaesthetics	R.A. Moore
HALSEY MJ	Minimum alveolar concentrations of noble gases, nitrogen, and sulfur hexafluoride in rats: helium and neon as nonimmobilizers (nonanesthetics)	1998	University of Oxford	Anaesthetics	D.D. Koblin Z. Fang E.I. Eger II
HALSEY MJ	Molecular similarity analysis: an alternative approach to studying molecular mechansims of anaesthesia	1998	University of Oxford	Anaesthetics	J.C. Sewell
HALSEY MJ	Hypothesis: volatile anesthetics produce immobility by acting on two sites approximately five carbon atoms apart	1999	University of Oxford	Anaesthetics	E.I. Eger II R.A. Harris D.D. Koblin
HALSEY MJ	Nonimmobilizers and transitional compounds may produce convulsions by two mechanisms	1999	University of Oxford	Anaesthetics	E.I. Eger II D.D. Koblin J. Sonner
HAHN CEW	The development of new microelectrode gas sensors: An Odyssey. Part IV: O2, CO2 and N2O reduction at unshielded gold microdisc electrodes	2000	University of Oxford	Anaesthetics	H. McPeak A.M.S. Bond
HAHN CEW	Electrochemical analysis of blood-gases, gases and vapours	1998	University of Oxford	Anaesthetics
HAHN CEW	A tidal breathing model for the Multiple Inert Gas Elimination Technique (MIGET)	1999	University of Oxford	Anaesthetics	J.P. Whiteley D.J. Gavaghan
HAHN CEW	Oxygen respiratory gas analysis by sinewave measurement: A theoretical model	1996	University of Oxford	Anaesthetics
GAVAGHAN DJ	An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data	2000	University of Oxford	Anaesthetics	R. Andrew Moore Henry J. McQuay
GAVAGHAN DJ	An exponentially expanding mesh ideally suited to the fast and efficient simulation of diffusion processes at microdis electrodes. 1. Derivation of the mesh	1998	University of Oxford	Anaesthetics
GAVAGHAN DJ	Adaptive finite element simulation of currents at microelectrodes to a guaranteed accuracy. Theory	2000	University of Oxford	Anaesthetics	Kathryn Harriman Paul Houston Endre Suli
GAVAGHAN DJ	A complete numerical simulation of the techniques of alternating current linear sweep and cyclic voltammetry: analysis of a reversible process by conventional and fast Fourier transform methods	2000	University of Oxford	Anaesthetics	A.M. Bond
GARRARD CS	The incidence and cause of coagulopathies in an intensive care population	1996	University of Oxford	Anaesthetics	R. Chakreverty S. Davidson K. Peggs
GARRARD CS	Principles and Practice of Critical Care	1997	University of Oxford	Anaesthetics	S. Westaby P. Foex
GARRARD CS	Effect of renal function on serum nitrogen oxide concentrations	1996	University of Oxford	Anaesthetics	I.M. Mackenzie A. Ekangaki D. Young
GARRARD CS	Autonomic control of skin microvessels: assessment by power spectrum of photoplethysmographic waves	1996	University of Oxford	Anaesthetics	L. Bernardi A. Radaelli P.K. Sold
Fee JPH	Effect of the addition of alfentanil to lignocaine during axillary brachial plexus anaesthesia	1996	The Queen's University of Belfast	Anaesthetics	Gormley WP Murray JM Bower S
Fee JPH	Cardiovascular effects of 50% nitrous oxide in older adult patients anaesthetized with isoflurane or halothane	1998	The Queen's University of Belfast	Anaesthetics	McKinney MS
Fee JPH	A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement	1996	The Queen's University of Belfast	Anaesthetics	Grace D
Fee JPH	Double-blind comparison of extradural block with three bupivacaine-ketamine mixtures in knee arthroplasty	1998	The Queen's University of Belfast	Anaesthetics	Weir PS
FOEX P	Myocardial ischemia and reperfusion are associated with an increased stiffness of remote nonischemic myocardium	1996	University of Oxford	Anaesthetics	S.C. Marsch S. Dalmas D.M. Philbin
FOEX P	Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats	2000	University of Oxford	Anaesthetics	R. Kato S. Ross
FOEX P	Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats	2000	University of Oxford	Anaesthetics	R. Kato
FOEX P	Effects and interactions of nitrous oxide, myocardial ischemia, and reperfusion on left ventricular diastolic function	1997	University of Oxford	Anaesthetics	S.C. Marsch S. Dalmas D.M. Philbin
EVANS RD	Preparation of radiolabelled very-low-density lipoprotein in high yield by extended rat liver perfusion	2000	University of Oxford	Anaesthetics	Mark J. Bennett David Hauton David G. Hole
EVANS RD	Effect of Endotoxin and platelet-activating factor on lipid oxidation in the rat heart	1997	University of Oxford	Anaesthetics	Xin Wang
EVANS RD	Alterations in myocardial lipid metabolism during lactation in the rat	1998	University of Oxford	Anaesthetics	Xin Wang David G. Hole Teresa H.M. Da Costa
EVANS RD	Utillization of very low density lipoprotein by rat heart: the effect of endotoxin	2000	University of Oxford	Anaesthetics	Mark J. Bennett David Hauton David G. Hole
Takata M	Coupled vs. uncoupled pericardial constraint: effects on cardiac chamber interactions	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Harasawa Y Beloucif S Robotham JL
Takata M	Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Abe J Tanaka H Kitano Y
Takata M	Intratracheal anti-tumor necrosis factor-alpha antibody attenuates ventilator-induced lung injury in rabbits	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Imai Y Kawano T Iwamoto S
Takata M	Congenital NOS2 deficiency protects mice from LPS-induced hyporesponsiveness to inhaled nitric oxide	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Weimann J Bloch KD Zapol WM
Robotham J	Effect of blood pressure changes on air flow dynamics in the upper airway of the decerebrate cat	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Mayor AH Schwartz AR Rowley JA
Robotham J	Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Yamamoto S Burman HP ODonnell CP
Robotham J	Reflex stimulation of renal sympathetic nerve activity and blood pressure in response to apnea	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	ODonnell C Schwartz AR Shirahata M
Robotham J	Inhibition of myocardial crossbridge cycling by hypoxic endothelial cells - A potential mechanism for matching oxygen supply and demand?	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Shah AM Mebazaa A Lakatta EG
Rice A S	Cannabinoid CB1 receptor expression in rat spinal cord	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Farquhar-Smith WP McMahon SB Elphick MR
Rice A S	The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Jaggar SI Hasnie FS Sellaturay S
Rice A S	The modulatory effects of Bradykinin B-1 and B-2 receptor antagonists upon viscero-visceral hyper-reflexia in a rat model of visceral hyperalgesia	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Jaggar SI Habib S
Rice A S	The role of nerve growth factor in a model of visceral inflammation	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Dmitrieva N Shelton D McMahon SB
Newton D E	Effect of remifentanil on the auditory evoked response and haemodynamic changes after intubation and surgical incision	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	McGregor RR Allan LG Thornton C
Newton D E	Middle latency auditory evoked responses and electroencephalographic derived variables do not predict movement to noxious stimulation during 1 minimum alveolar anesthetic concentration isoflurane nitrous oxide anesthesia	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Kochs E Kalkman CJ Thornton C
Newton D E	Remifentanil reduces auditory and somatosensory evoked responses during isoflurane anaesthesia in a dose-dependent manner	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Crabb I Thornton C Konieczko KM
Newton D E	Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 2: Auditory and somatosensory evoked responses	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Thornton C Lucas MA Jones RM
Nagy I	Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Ahluwalia J Urban L Bevan S
Nagy I	Spinal neurokinin NK1 receptor down-regulation and antinociception: Effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Hua XY Chen P Polgar E
Nagy I	Noxious heat activates all capsaicin-sensitive and also a sub- population of capsaicin-insensitive dorsal root ganglion neurons	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Rang HP
Nagy I	Similarities and differences between the responses of rat sensory neurons to noxious heat and capsaicin	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Rang HP
Maze M	Antisense technology reveals the alpha(2A) adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Mizobe T Maghsoudi K Tianzhi G
Maze M	Substitution of a mutant alpha(2a)-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Lakhlani PP MacMillan LB Guo TZ
Maze M	Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of alpha2B adrenoceptors	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Sawamura S Kingery WS Davies MF
Maze M	Arrangement of transmembrane domains in adrenergic receptors - Similarity to bacteriorhodopsin	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Mizobe T Lam V Kobilka BK
Holdcroft A I	Pain relief with oral cannabinoids in familial Mediterranean fever	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Smith M Jacklin A Hodgson H
Holdcroft A I	Arterial to inspired partial pressure ratio of halothane, isoflurane, sevoflurane and desflurane in rats	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Sapsed-Byrne SM Ma D Lockwood GG
Holdcroft A I	Heat retention using passive systems during anaesthesia: Comparison of two plastic wraps, one with reflective properties	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Deacock S
Holdcroft A I	Estrous cycle phase variations in visceromotor and cardiovascular responses to colonic distension in the anesthetized rat	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Sapsed-Byrne SM Ma DQ Ridout D
Fujinaga M	Modulation of vascular development and injury by angiotensin II	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Hutchinson HG Hein L Pratt RE
Fujinaga M	Assessment of teratogenic effects of lidocaine in rat embryos cultured in vitro	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics
Fujinaga M	alpha(1)-Adrenergic stimulation perturbs the left-right asymmetric expression pattern of nodal during rat embryogenesis	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Lowe LA Kuehn MR
Fujinaga M	Antinociceptive response to nitrous oxide is mediated by supraspinal opiate and spinal alpha(2) adrenergic receptors in the rat	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Anaesthetics	Guo TZ Poree L Maze M
Saunders B P	A new variable stiffness colonoscope makes colonoscopy easier: a randomised controlled trial	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Brooker JC Shah SG Williams CB
Saunders B P	Real-time magnetic three-dimensional imaging of flexible endoscopy	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Williams CB Bell GD Bladen JS
Saunders B P	Magnetic imaging of colonoscopy: an audit of looping, accuracy and ancillary maneuvers	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Shah SG Brooker JC Williams CB
Saunders B P	Effect of magnetic endoscope imaging on colonoscopy performance: a randomised controlled trial	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Shah SG Brooker JC Williams CB
Nicholls J	Permanent sacral nerve stimulation for fecal incontinence	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Malouf AJ Vaizey CJ Kamm MA
Nicholls J	Long-term results of overlapping anterior anal-sphincter repair for obstetric trauma	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Malouf AJ Norton CS Kamm MA
Nicholls J	Effects of short term sacral nerve stimulation on anal and rectal function in patients with anal incontinence	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Vaizey CJ Kamm MA Turner IC
Nicholls J	Clinical, physiological, and radiological study of a new purpose-designed artificial bowel sphincter	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Vaizey CJ Kamm MA Bartram CI
McGregor A H	Measuring spinal motion in rowers; use of an electromagnetic device	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Bull AMJ
McGregor A H	Spinal motion in lumbar degenerative disc disease	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Cattermole HR Hughes SPF
McGregor A H	The effect of symptom distribution on the motion characteristics of the lumbar spine	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Dore CJ McCarthy ID Hughes SP
McGregor A H	Quantitative assessment of the motion of the lumbar spine in the low back pain population and the effect of different spinal pathologies of this motion	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	McCarthy ID Dore CJ Hughes SPF
Khullar V	Prevalence of faecal incontinence among women with urinary incontinence	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Damiano R Toozs-Hobson P Cardozo L
Khullar V	Ultrasound: A noninvasive screening test for detrusor instability	1996	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Cardozo LD Salvatore S Hills S
Khullar V	GAX collagen in the treatment of urinary incontinence in elderly women: A two year follow up	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Cardozo LD Abbott D Anders K
Khullar V	A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Kelleher CJ Cardozo LD Salvatore S
Kamm M A	Persistent pain and faecal urgency after stapled haemorrhoidectomy	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Cheetham MJ Mortensen NJM Phillips RKS
Kamm M A	Primary degeneration of the internal anal sphincter as a cause of passive faecal incontinence	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Vaizey CJ Bartram CI
Kamm M A	Treatment of impaired defecation associated with rectocele by behavioral retraining (biofeedback)	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Mimura T Roy AJ Storrie JB
Kamm M A	Relationship between anatomic and symptomatic long-term results after rectocele repair for impaired defecation	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Van Laarhoven CJHM Bartram CI Phillips RKS
Hughes S P	Instantaneous center of rotation and instability of the cervical spine - A clinical study	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Lee SW Draper ERC
Hughes S P	Nitric oxide in fracture repair - Differential localisation, expression and activity of nitric oxide synthases	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Corbett SA Hukkanen M Polak JM
Hughes S P	Sensory and sympathetic innervation of the vertebral endplate in patients with degenerative disc disease	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Brown MF Hukkanen MVJ Polak JM
Hughes S P	Nitric oxide mediated vasoreactivity during fracture repair	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Corbett SA McCarthy ID Polak JM
Gould S W	Upright dynamic MR defaecating proctography in an open configuration MR system	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Lamb GM Darzi A Gedroyc WMW
Gould S W	Interventional MR-guided excisional biopsy of breast lesions	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Lamb G Gedroyc W Darzi A
Gould S W	Laparoscopic surgery in a 0.5-t interventional magnetic resonance unit	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Gedroyc W Darzi A
Gould S W	Rigid videosigmoidoscopy vs conventional sigmoidoscopy - A randomized controlled study	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Taffinder NJ Taylor P Darzi A
Gedroyc W M	Meniscal movement - An in-vivo study using dynamic MRI	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Vedi V Williams A Tennant SJ
Gedroyc W M	Magnetic resonance-guided percutaneous laser ablation of uterine fibroids	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Law P Regan L
Gedroyc W M	MRI guidance of infra-red laser liver tumour ablations, utilising an open MRT configuration system; technique and early progress	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	de Jode MG Lamb GM Taylor-Robinson SD
Gedroyc W M	MR-guided laser thermoablation of inoperable renal tumours in an open-configuration interventional scanner: Preliminary clinical experience in three cases	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	de Jode MG Vale JA
Emmanuel A	Laser Doppler measurement of rectal mucosal blood flow	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Kamm MA
Emmanuel A	Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Kamm MA Roy AJ Antonelli K
Emmanuel A	Laser Doppler flowmetry as a measure of extrinsic colonic innervation in functional bowel disease	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Kamm MA
Emmanuel A	Reproducible assessment of vaginal and rectal mucosal and skin blood flow: laser doppler fluximetry of the pelvic microcirculation	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Kamm MA Beard RW
Darzi A	Laparoscopic versus open repair of groin hernia: a randomised comparison	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	O'Dwyer P Macintyre I Grant A
Darzi A	Effect of sleep deprivation on surgeons dexterity on laparoscopy simulator	1998	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Taffinder NJ McManus IC Russell RCG
Darzi A	The effect of a second-generation 3D endoscope on the laparoscopic precision of novices and experienced surgeons	1999	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Taffinder N Smith SGT Russell RCG
Darzi A	Hand-assisted laparoscopic surgery (HALS) with the HandPort System - Initial experience with 68 patients	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Litwin DEM Jakimowicz J Kelly JJ
Bartram C	Magnetic resonance imaging of the pelvic floor in patients with obstructed defaecation	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Healy JC Halligan S Kamm MA
Bartram C	Dynamic MR imaging of the pelvic floor in asymptomatic subjects	2000	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Goh V Halligan S Healy JC
Bartram C	Transvaginal versus anal endosonography for detecting damage to the anal sphincter	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Frudinger A Kamm MA
Bartram C	Perineal examination as a predictor of underlying external anal sphincter damage	1997	Imperial College of Science, Technology	Anaesthetics + Surgery - Surgery	Frudinger A Spencer JAD Kamm MA
Van der Molen T.	Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma.	1997	University of Aberdeen	Asthma	Postma, D.S. Schreurs, A.J. Bosveld, H.E.
Van der Molen T.	Effects of the long acting b agonist formoterol on asthma control in asthma patients using inhaled corticosteroids.	1997	University of Aberdeen	Asthma	Postma, D.S. Turner, M.O. Jong, B.M.
Van der Molen T.	Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires.	1998	University of Aberdeen	Asthma	Sears, M.R. de Graaf, C.S. Postma, D.S.
Van der Molen T.	Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment.	1998	University of Aberdeen	Asthma	Meyboom-de Jong, B. Mulder, H.H. Postma, D.S.
Seaton A.	Bronchial reactivity and dietary antioxidants.	1997	University of Aberdeen	Asthma	Soutar, A. Brown, K.
Seaton A.	Diet and childhood asthma in a society in transition: a study in urban and rural Saudi Arabia.	2000	University of Aberdeen	Asthma	Hijazi, N. Abalkhail, B.
Seaton A.	Asthma and respiratory symptoms in urban and rural Saudi Arabia.	1998	University of Aberdeen	Asthma	Hijazi, N. Abalkhail, B.
Seaton A.	Particulate air pollution and the blood.	1999	University of Aberdeen	Asthma	Soutar, A. Crawford, V. Elton, R.
Osman L.M.	Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease.	1997	University of Aberdeen	Asthma	Godden, D.J. Friend, J.A. Legge, J.S.
Osman L.M.	Integrated care for asthma: matching care to the patient.	1996	University of Aberdeen	Asthma	Abdalla, M.I. Russell, I.T. Fiddes, J.
Osman L.M.	Symptoms, quality of life, and health service contact amoung young adults with mild asthma.	2000	University of Aberdeen	Asthma	Calder, C. Robertson, R. Friend, J.A.
Osman L.M.	Measuring quality of life for young children with asthma and their families.	1996	University of Aberdeen	Asthma	Silverman, M.
Helms P.J.B.	Seasonal variation in Sudden Infant Death Syndrome and Bronchiolitis-a common mechanism?	1996	University of Aberdeen	Asthma	Gupta, R. Jolliffe, I.T. Douglas, A.S.
Helms P.J.B.	Lack of linkage between chromosome 5q22-33 markers and IgE/bronchial hyperreactivity in 67 Scottish families.	2000	University of Aberdeen	Asthma	Mansur, A.H Christie, G. Turner, A.
Helms P.J.B.	Outcome for children of parents with atopic asthma and transient childhood wheezy bronchitis.	1997	University of Aberdeen	Asthma	Christie, G. Ross, S.J. Godden, D.G.
Helms P.J.B.	Asthma, wheezy bronchitis and atopy across two generations.	1999	University of Aberdeen	Asthma	Christie, G.L. Godden, D.J. Ross, S.J.
Godden D.J.	Family size, childhood infections and atopic diseases.	1998	University of Aberdeen	Asthma	Bodner, C. Seaton, A.
Godden D.J.	Antioxidant intake and adult-onset wheeze: a case control study. Aberdeen WHEASE Study Group.	1999	University of Aberdeen	Asthma	Bodner C Brown K Little J
Godden D.J.	Risk factors for adult onset wheeze: a case-control study.	1998	University of Aberdeen	Asthma	Bodner, C.H. Ross, S. Little, J.
Godden D.J.	Childhood exposure to infection and risk of adult onset wheeze and atopy.	2000	University of Aberdeen	Asthma	Bodner, C. Anderson, W.J. Reid. T.S.
WOJNAROWSKA FT	A comparison of the expression of known basement membrane components with the linear IgA disease antigens using the novel substrate cylindroma	1999	University of Oxford	Autoimmunity	Allen J Collier PM Leigh IM
WOJNAROWSKA FT	Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression	1999	University of Oxford	Autoimmunity	Collier PM Welsh K McGuire W
WOJNAROWSKA FT	Lichen sclerosus premenarche: autoimmunity and immunogenetics	2000	University of Oxford	Autoimmunity	Powell J Winsey S Marren P
WOJNAROWSKA FT	The localization of target antigens and autoantibodies in linear IgA disease is variable: correlation of immunogold electron microscopy and immunoblotting	1998	University of Oxford	Autoimmunity	Zhou S Ferguson DJP Allen J
WILLCOX HNA	Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells	1999	University of Oxford	Autoimmunity	Urban, B.C. Ferguson, D.J.P. Pain, A.
WILLCOX HNA	Spontaneous neutralising antibodies to interferon-a and interleukin-12 in thymoma-associated autoimmune disease	1997	University of Oxford	Autoimmunity	Meager, A. Vincent, A. Newsom-Davis, J.
WILLCOX HNA	A pathogenetic role for the thymona in myasthenia gravis: autosensitization of IL4-producing T cell clones recognising extracellular AChR epitopes presented by minority class II isotypes.	1998	University of Oxford	Autoimmunity	Nagvekar, N. Moody, A.M. Roxanis, I.
WILLCOX HNA	Early-onset myasthenia gravis: A recurring T-cell epitope in the adult-specific acetylcholine receptor + subunit presented by the susceptibility allele HLA-DR52a	1999	University of Oxford	Autoimmunity	Hill. M. Beeson, D. Moss, P.
VINCENT AC	Autoantibody screening in subacute cerebellar ataxia	2000	University of Oxford	Autoimmunity	Trivedi, R. Mundanthanam, G. Amyes, B.
VINCENT AC	Autoantibodies Detected to Expressed K+ Channels are Implicated in Neuromyotonia	1997	University of Oxford	Autoimmunity	Hart, I.K. Water, C. Newland, C.
POWRIE FM	A critical role for TGF-b but not IL-4 in the suppression of Th type 1 mediated colitis by CD45RBlow CD4+ T cells	1996	University of Oxford	Autoimmunity	Carlino J. Leach M.W. Mauze S.
POWRIE FM	CTLA4 plays an essential role in the function of CD25+CD4+ regulatory cells that control Intestinal Inflammation	2000	University of Oxford	Autoimmunity	Read S. Malmstrom V.
POWRIE FM	An Essential Role for Interleukin 10 in the Function of Regulatory T Cells that Inhibit Intestinal Inflammation	1999	University of Oxford	Autoimmunity	Asseman C. Mauze S. Leach M.W.
PEACH B	Human autoantibodies specific for the +1A calcium chanel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons	1998	University of Oxford	Autoimmunity	Pinto, A Gillard, S Moss, F
PEACH B	Effect of Lambert-Eaton Myasthenic Syndrome Antibodies on Automomic Neurons in the Mouse	1997	University of Oxford	Autoimmunity	Waterman, S.A. Newsom-Davis, J.
PEACH B	Small cell lung cancer, paraneoplastic cerebellar	1997	University of Oxford	Autoimmunity	Mason, W.P. Graus, F. Honnorat, J.
PEACH B	Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome	1996	University of Oxford	Autoimmunity	Bain, P.G. Motomura, M.D. Newsom-Davis, J.
NEWSOM-DAVIS J	A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis	1996	University of Oxford	Autoimmunity	Palace, J. Lecky, B.
HALL FC	Isolating the molecular suspect: HLA transgenic mice in the study of human autoimmune disease	1999	University of Oxford	Autoimmunity	Cope AP Patel SD Sonderstrup G
HALL FC	TCR beta spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes	1998	University of Oxford	Autoimmunity	Thomson K McMichael A Wordsworth BP
EBERS GC	Multiple Sclerosis	1998	University of Oxford	Autoimmunity	Paty, D.W.
EBERS GC	A full genome search in multiple sclerosis	1996	University of Oxford	Autoimmunity	Kukay, K. Bulman Sadovnik, A.D.
CORNALL RJ	Role of Syk in B-cell development and antigen-receptor signaling	2000	University of Oxford	Autoimmunity	Cheng AM Pawson T Goodnow C
CORNALL RJ	Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway	1999	University of Oxford	Autoimmunity	Goodnow CC Cyster JG
CORNALL RJ	Polygenic Autoimmune Traits: Lyn, CD22, and SHP-1 Are Limiting Elements of a Biochemical Pathway Regulating BCR Signaling and Selection	1998	University of Oxford	Autoimmunity	Cyster JG Hibbs ML Goodnow C
CORNALL RJ	B cell antigen receptor signalling in the balance of tolerance and immunity	1998	University of Oxford	Autoimmunity	Goodnow CC
CALLAN MFC	CD8+ T cell selection, function and death in the primary immune response in vivo	2000	University of Oxford	Autoimmunity	Wilson J McMichael A Rickinson AB
CALLAN MFC	A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers	1999	University of Oxford	Autoimmunity	Tan LC McMichael A Rickinson AB
CALLAN MFC	Direct visualisation of antigen-specific CD8+ T cells during primary immune response to Epstein-Barr virus in vivo	1998	University of Oxford	Autoimmunity	Tan L Ogg GS Rickinson AB
CALLAN MFC	Large clonal expansions of CD8+ T cells in acute infectious mononucleosis	1996	University of Oxford	Autoimmunity	Steven N Krausa P Wilson JDK
BEESON DMW	IgG from seronegative myasthenia gravis patients binds to TE671 cells but not to human AChR expressed in HEK 293 cells	2000	University of Oxford	Autoimmunity	Blaes, F. Plested, P. Lang, B.
Williams O	The action of Bax and Bcl-2 on T cell selection	1998	University College London	Cancer	Norton T Halligey M Kioussis D
Williams O	Interactions with multiple peptide ligands determine the fate of developing thymocytes	1998	University College London	Cancer	Tarazona R Wack A Harker N
Williams O	Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes	1998	University College London	Cancer	Smyth LA Huby RDJ Norton T
Williams O	Susceptibility and resistance to antigen-induced apoptosis in the thymus of transgenic mice.	1998	University College London	Cancer	Tarazona R Moskophidis L Smyth LA
Whelan J.S.	Osteosarcoma	1997	University College London	Cancer
Wells M	Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary	1997	University of Sheffield	Cancer	Arora DS Cooke IE Ganesan TS
Wells M	Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia	1998	University of Sheffield	Cancer	Maitland NJ Conway S Wilkinson NS
Wells M	Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: Correlation with up-regulation in epithelial ovarian cancer	1999	University of Sheffield	Cancer	Katso RMT Manek S Biddolph S
Wells M	A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettege specimens	1999	University of Sheffield	Cancer	Bergeron C Nogales FF Masseroli M
Walker LG	Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer	1999	University of Hull	Cancer	Heys SD Walker MB Ogston K
Walker LG	Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy	1999	University of Hull	Cancer	Walker MB Ogston K Heys SD
Walker LG	Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer	1998	University of Hull	Cancer	Gilbert FJ Cordiner CM Affleck IR
Walker LG	Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer - A meta-analysis of randomized controlled clinical trials	1999	University of Hull	Cancer	Heys SD Smith I Eremin O
Turnbull LW	Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for the evaluation of symptomatic breast lesions.	1999	University of Hull	Cancer	Drew PJ Chatterjee S Read S
Turnbull LW	Routine screening for local recurrence following breast - conserving therapy for cancer with dynamic contrast - enhanced magnetic resonance imaging of the breast.	1998	University of Hull	Cancer	Drew PJ Kerin MJ Imrie M
Turnbull LW	In vivo magnetic resonance spectroscopy and dynamic contrast enhanced imaging of the prostate gland	1998	University of Hull	Cancer	Liney GP Knowles AJ
Turnbull LW	Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer.	1999	University of Hull	Cancer	Drew PJ Chatterjee S Read J
Tidy JA	A common polymorphism acts as an intragenic modifier of mutant p53 behaviour	2000	University of Sheffield	Cancer	Marin MC Jost CA Brooks LA
Tidy JA	Outcome after surgical resection for high-grade and intraepithelial neoplasia (Bowen's disease)	1999	University of Sheffield	Cancer	Brown SR Skinner P Smith JH
Tidy JA	MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue	1998	University of Sheffield	Cancer	Gillespie AM Rodgers S Coleman RE
Tidy JA	Relation between tissue structure and imposed electrical current flow in cervical neoplasia	2000	University of Sheffield	Cancer	Brown BH Boston K Smallwood RH
Thomas MG	Vitamin D3 receptor expression in colorectal cancer	1999	University of Bristol	Cancer	Sylvester,PA Newcomb,PV Longman,RJ
Thomas MG	Lack of mucin MUC5AC field change expression in tubulovillous and villous colorectal adenomas	2000	University of Bristol	Cancer	Longman,RJ Douthwaite,JA Sylvester,PA
Thomas MG	The steroid Vitamin D3 reduces cell proliferation in human duodenal epithelium	1997	University of Bristol	Cancer	Sturgess,RP Lombard,M
Thomas MG	Trefoil peptides and surgical disease	1999	University of Bristol	Cancer	Longman,RJ Poulsom,R
Teare MD	A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability	2000	University of Sheffield	Cancer	Healey CS Dunning AM Chase D
Teare MD	Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours	2000	University of Sheffield	Cancer	Rapley EA Crockford GP Biggs P
Teare MD	Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22	2000	University of Sheffield	Cancer	Rahman N Seal S Renard H
Teare MD	The extent of linkage disequilibrium in four populations with distinct demographic histories	2000	University of Sheffield	Cancer	Dunning AM Durocher F Healey CS
Summerton N	Diagnosis and General Practice	2000	University of Hull	Cancer
Summerton N	Trends in negative defensive medicine within general practice	2000	University of Hull	Cancer
Summerton N	The medicine of primary care	1999	University of Hull	Cancer
Summerton N	The clinical assessment of patients with large bowel symptoms by general practitioners	2000	University of Hull	Cancer	Paes RA
Stewart-Paton CEH	Enhancement of insulin-like growth factor I activity by novel antisera: potential structure/function interactions	2000	University of Bristol	Cancer	Pell,JM Hill,RA Weston,CR
Stewart-Paton CEH	Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis	1999	University of Bristol	Cancer	Newcomb,PV Savage,PB Dickens,M
Stewart-Paton CEH	Increased tyrosine kinase activity but not calcium mobilisation is required for ceramide-induced apoptosis	1999	University of Bristol	Cancer	Mihai,R Holly,JMP
Stewart-Paton CEH	Tumour necrosis factor-alpha induced apoptosis is associated with supression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts	1999	University of Bristol	Cancer	Meadows,KA Holly,JMP
Sharma S.K.	Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent	1999	University College London	Cancer	Pedley P B Boxer G M Boden R
Sharma S.K.	Catalytic activity of an in vivo tumor targeted anti-CEA sc Fv: carboxypeptidase G2 fusion protein	2000	University College London	Cancer	Bhatia J Chester K A Pedley R B
Sharma S.K.	Developments with targeted enzymes in cancer therapy	1999	University College London	Cancer	Bagshawe K D Burke P J Melton R G
Sharma S.K.	ZD2767 An improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts	1996	University College London	Cancer	Blakey D C Burke P J Davies D H
Sanders C	Transcription factor-dependent loading of the E1 initiator reveals modular assembly of the papillomavirus origin melting complex	2000	University of Sheffield	Cancer	Stenlund A
Sanders C	Structure of the intact transactivation domain of the human papillomavirus E2 protein	2000	University of Sheffield	Cancer	Antson AA Burns JE Moroz OV
Sanders C	Recruitment and loading of the E1 initiator protein: An ATP-dependent process catalysed by a transcription factor	1998	University of Sheffield	Cancer	Stenlund A
Sanders C	Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells	1998	University of Sheffield	Cancer	Daniels PR Maitland NJ
Sala A	Activation of human B-MYB by cyclins	1997	University College London	Cancer	Kundu M Casella I Engelhard A
Sala A	B-MYB transactivates its own promoter through SP1-binding sites	1999	University College London	Cancer	Saitta B De Luca P Cervellera MN
Sala A	Direct transactivation of the anti-apoptotic gene apolipoprotein J (clusterin) by B-MYB.	2000	University College London	Cancer	Cervellera M Raschella G Santilli G
Sala A	Poly(ADP-ribose) polymerase is a B-MYB coactivator.	2000	University College London	Cancer	Cervellera MN
Royds JA	Effects of interleukin-1 and dexamethasone on interleukin-6 production and growth in human meningiomas	1997	University of Sheffield	Cancer	Jones TH Justice SK Timperley WR
Royds JA	The association between nm23 gene expression and survival in patients with sarcomas	1997	University of Sheffield	Cancer	Robinson MH Stephenson T Rees RC
Royds JA	Effect of mutation and conformation on the function of p53 in colorectal cancer	2000	University of Sheffield	Cancer	Webley KM Shorthouse AJ
Royds JA	High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers	1997	University of Sheffield	Cancer	Fredersdorf S Burns J Milne AM
Rennie IG	Association of specific chromosome alterations with tumour phenotype in posterior uveal melanoma	2000	University of Sheffield	Cancer	Sisley K Parsons MA Graham J
Rennie IG	Infrequent expression of the MAGE gene family in uveal melanomas	1996	University of Sheffield	Cancer	Mulcahy KA Boon T Rees RC
Rennie IG	Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis	1997	University of Sheffield	Cancer	Sisley K Parsons MA Jacques R
Rennie IG	alpha-Melanocyte-stimulating hormone inhibits NF-kappa B activation in human melanocytes and melanoma cells	1999	University of Sheffield	Cancer	Haycock JW Wagner M Mac Neil S
Price C	Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14.	1998	University College London	Cancer	Garcia Marco JA Nouel A Navarro B
Price C	Frequent somatic deletion of the 13q12.3 locus encompassing BRCA2 in chronic lymphocytic leukemia.	1996	University College London	Cancer	Garcia Marco JA Caldas C Wiedemann LM
Price C	MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes.	1997	University College London	Cancer	So CW Ma ZG Dong S
Price C	Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia.	1998	University College London	Cancer	Ford AM Bennett CA Bruin MC
Mott MG	Early Identification of Anthracycline Cardiomyopathy	1996	University of Bristol	Cancer	Bu'Lock,FA Martin,RP
Mott MG	The United Kingdom Children's Cancer Study Group - the first twenty years of Growth and Development	1997	University of Bristol	Cancer	Mann,JR Stiller,CA
Mott MG	Variation in Survival for Pediatric Malignancies within a region of the United Kingdom	1996	University of Bristol	Cancer	Foreman,NK Thorne,RN
Mott MG	Glycophorin A mutations and risk of secondary laeukaemia in patients treated for childhood acute lymphoblastic leukaemia	1996	University of Bristol	Cancer	Boyse,J Hewitt,M
Moss SE	Immunological development and cardiovascular function are normal in Annexin VI null mutant mice.	1999	University College London	Cancer	Hawkins TE Roes J Rees D
Moss SE	Endocytic vesicles move at the tips of actin tails in cultured mast cells.	1999	University College London	Cancer	Merrifield CJ Ballestrem C Imhof BA
Moss SE	A conserved nuclear element with a role in mammalian gene regulation.	1999	University College London	Cancer	Donnelly SR Hawkins TE
Moss SE	Annexin 5 mediates a peroxide-induced Ca(2+) influx in B cells.	1999	University College London	Cancer	Kubista H Hawkins TE Patel DR
Monson JR	Patterns of recurrence and survival after laparoscopic and conventional resection for colorectal carcinoma	2000	University of Hull	Cancer	Hartley JE Mehigan BJ MacDonald AW
Monson JR	Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer	2000	University of Hull	Cancer	Chin KF Greenman J Gardiner E
Monson JR	Artificial neural networks applied to outcome prediction for colorectal cancer patients in separate institutions	1997	University of Hull	Cancer	Bottaci L Drew PJ Hartley JE
Monson JR	Prospective comparison of standard triple assessment and dynamic magnetic resonance imaging of the breast for evaluation of symptomatic breast lesions	1999	University of Hull	Cancer	Drew PJ Turnbull LW Chatterjee S
Meuth M	Loss of heterozgosity and base substitution at the APRT locus in mismatch-repair-proficient and -deficient colorectal carcinoma cell lines	1996	University of Sheffield	Cancer	Phear G Bhattacharyya NP
Meuth M	Conditional mutator phenotypes in hMSH2-deficient tumor cell lines	1997	University of Sheffield	Cancer	Richards B Zhang H Phear G
Meuth M	Mutator phenotype in Msh-2-deficient murine embryonic fibroblasts	1997	University of Sheffield	Cancer	Reitmair AH Risley R Bristow RG
Meuth M	Apoptosis induced by overexpression of hMSH2 or hMLH1	1999	University of Sheffield	Cancer	Zhang H Richards B Wilson T
Matter K	The cytoplasmic domains of a beta1 integrin mediate polarization in Madin-Darby canine kidney cells by selective basolateral stabilization.	1998	University College London	Cancer	Gut A Balda MS
Matter K	Carbohydrate-mediated Golgi to cell surface transport and apical targeting of membrane proteins.	1998	University College London	Cancer	Gut A Kappeler F Hyka N
Matter K	Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens.	1998	University College London	Cancer	Minskoff SA Mellman I
Matter K	Occludin modulates transepithelial migration of neutrophils.	2000	University College London	Cancer	Huber D Balda MS
Makris A.	Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer	1999	University College London	Cancer	Chang J Powles T J Allred D C
Mac Neil S	alpha-Melanocyte-stimulating hormone inhibits NF-kappa B activation in human melanocytes and melanoma cells	1999	University of Sheffield	Cancer	Haycock JW Wagner M Rennie IG
Mac Neil S	Investigation of female survival benefit in metastatic melanoma	1999	University of Sheffield	Cancer	Richardson B Price A Wagner M
Mac Neil S	Tamoxifen, 17 beta-oestradiol and the calmodulin antagnosit J8 inhibit human melanoma cell invasion through fibronectin	1997	University of Sheffield	Cancer	Dewhurst LO Gee JW Rennie IG
Mac Neil S	alpha-melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines	1998	University of Sheffield	Cancer	Hedley SJ Gawkrodger DJ Weetman AP
Lind MJ	Phase I study of pharmacologically based dosing of carboplatin with filgrastim support in women with epithelial ovarian cancer	1996	University of Hull	Cancer	GhazalAswad S Gumbrell L Fishwick K
Lind MJ	Preclinical and phase I clinical studies with the nonclassical antifolate thymidylate synthase inhibitor nolatrexed dihydrochloride given by prolonged administration in patients with solid tumours	1998	University of Hull	Cancer	Rafi I Boddy AV Calvete JA
Lind MJ	Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapyplus filgrastim alone in patients with ovarian cancer	1998	University of Hull	Cancer	Weaver A Chang J Wrigley E
Lind MJ	O-6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma	1998	University of Hull	Cancer	Middleton MR Lunn JM Morris C
Linch D.C.	Primitive myeloid cells express high levels of phospholipase A(2) activity in the absence of leukotriene release: selective regulation by stem cell factor involving the MAP kinase pathway	1999	University College London	Cancer	Roberts P J Mollapour E Watts M J
Linch D.C.	Characterization of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation	1997	University College London	Cancer	Williams C D Watts M J Thomas N S B
Linch D.C.	Transmigration of CD34+ cells across specialized and non-specialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31)	1998	University College London	Cancer	Yong K L Watts M J Thomas N S
Linch D.C.	A truncated insoform of the human beta chain common to the receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 with increased mRNA expression in some patients with acute leukemia	1998	University College London	Cancer	Gale R E Freeburn R W Khwaja A
Lewis CE	Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro	2000	University of Sheffield	Cancer	Bootle-Wilbraham CA Tazzyman S Marshall JM
Lewis CE	Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas	2000	University of Sheffield	Cancer	Lewis JS Landers RJ Underwood JCE
Lewis CE	The macrophage - a novel system to deliver gene therapy to pathological hypoxia	2000	University of Sheffield	Cancer	Griffiths L Binley K Iqball S
Lewis CE	Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma	1996	University of Sheffield	Cancer	Leek RD Whitehouse R Greenall M
Levine TP	p47 is a cofactor for p97-mediated membrane fusion.	1997	University College London	Cancer	Kondo H Rabouille C Newman R
Levine TP	Inositol phosphorylceramide synthase is located in the Golgi apparatus of Saccharomyces cerevisiae.	2000	University College London	Cancer	Wiggins CA Munro S
Levine TP	The vesicle docking protein p115 binds GM130, a cis-Golgi matrix protein, in a mitotically regulated manner.	1997	University College London	Cancer	Nakamura N Lowe M Rabouille C
Levine TP	The pleckstrin homology domain of oxysterol-binding protein recognises a determinant specific to Golgi membranes.	1998	University College London	Cancer	Munro S
Lennard L	Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations	1998	University of Sheffield	Cancer	Lancaster DL Rowland K Vora AJ
Lennard L	Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms	1997	University of Sheffield	Cancer	Otterness D Szumlanski C Klemetsdal B
Lennard L	Non-compliance with oral chemotherapy in childhood leukaemia - An overlooked and costly cause of late relapse	1996	University of Sheffield	Cancer	Lilleyman JS
Lennard L	Thiopurine methyltransferase pharmacogenetics: Human gene cloning and characterization of a common polymorphism	1996	University of Sheffield	Cancer	Szumlanski C Otterness D Her C
Khwaja A.	Lack of correlation between activation of Jun-NH2-terminal kinase and induction of apoptosis after detachment of epithelial cells	1997	University College London	Cancer	Downward J
Khwaja A.	Caspase mediated proteolysis and activation of protein kinase Cdelta plays a central role in neutrophil apoptosis	1999	University College London	Cancer	Tatton E L
Khwaja A.	Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras	1997	University College London	Cancer	Rodriguez-Viciana P Warne P H Marte B M
Khwaja A.	Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway	1997	University College London	Cancer	Rodriguez-Viciana P Wennstrom S Warne P H
Hubank M	Representational difference analysis of cDNA for the detection of differential gene expression in bacteria: development using a model of iron-regulated gene expression in Neisseria meningitidis.	1999	University College London	Cancer	Bowler LD Spratt BG
Hubank M	Identification of androgen-regulated genes in mouse kidney by representational difference analysis and random arbitrarily primed polymerase chain reaction	1998	University College London	Cancer	Melia MJ Bofill N Meseguer A
Hubank M	DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage	1999	University College London	Cancer	Jimenez GS Bryntesson F Torres-Arzayus M
Hubank M	cDNA representational difference analysis: a sensitive and flexible method for identification of differentially expressed genes	1999	University College London	Cancer	Schatz DG
Howard D.J.	Craniofacial resection for tumors of the nasal cavity and paranasal sinuses--a 17 year experience	1998	University College London	Cancer	Lund V J Wei W I Cheesman A D
Howard D.J.	Management options and survival in malignant melanoma of the sinonasal mucosa	1999	University College London	Cancer	Lund V J Harding L Wei W I
Howard D.J.	A third decade's experience with the gastric pull-up operation for hypopharyngeal carcinoma: changing patterns of use	1999	University College London	Cancer	Hartley B E Bottrill I D
Howard D.J.	Prevention before cure	1999	University College London	Cancer
Holly JMP	Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.	2000	University of Bristol	Cancer	Williams,AC Collard,TJ Perks,CM
Holly JMP	Insulin-like growth factor binding protein-3 (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF dependent manner	1997	University of Bristol	Cancer	Gill,ZP Perks,CM Newcomb,PV
Holly JMP	Active and inhibitory components of the insulin-like growth factor binding protein-3 protease system in adult serum, interstitial, and synovial fluid	1998	University of Bristol	Cancer	Maile,LA Xu,S Cwyfan-Hughes,SC
Holly JMP	The role of cell surface attachment and proteolysis in the IGF-independent effects of IGFBP-3 on apoptosis in breast epithelial cells	1999	University of Bristol	Cancer	Maile,LA Gill,ZP Perks,CM
Hann IM	Randomised comparison of addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial	1998	University College London	Cancer	Burnett AK Goldstone AH Stevens RM
Hann IM	The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial	1998	University College London	Cancer	Grimwade D Walker H Oliver F
Hann IM	Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutation	1996	University College London	Cancer	Formstone CJ Hallan PJ Tuddenham EG
Hann IM	Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukaemia: Results of the Medical Research Councils 10th AML trial (MRC AML 10)	1997	University College London	Cancer	Stevens RF Goldstone AH Rees JK
Hanks GWC	Opioid responsiveness	1997	University of Bristol	Cancer	Forbes,K
Hanks GWC	Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction	1998	University of Bristol	Cancer	Hardy,J Ling,J Mansi,J
Hanks GWC	The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo	2000	University of Bristol	Cancer	O'Neill,WM Simpson,P Fallon,MT
Hanks GWC	Morphine in cancer pain: modes of administration	1996	University of Bristol	Cancer	De Conno,F Ripamonti,C
Hancock BW	Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studies	1997	University of Sheffield	Cancer	Aitken M Radstone C Hudson GV
Hancock BW	Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment	2000	University of Sheffield	Cancer	Swerdlow AJ Barber JA Hudson GV
Hancock BW	Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate	1997	University of Sheffield	Cancer	Gillespie AM Lorigan PC Coleman RE
Hancock BW	Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin as second-line therapy for low risk disease	2000	University of Sheffield	Cancer	Dobson LS Lorigan PC Coleman RE
Hamdy FC	Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom	1999	University of Sheffield	Cancer	Donovan JL Frankel SJ Faulkner A
Hamdy FC	Expression of bcl-2, bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: Relationship with apoptosis and proliferation	1998	University of Sheffield	Cancer	Johnson MI Robinson MC Marsh C
Hamdy FC	Immunolocalization and messenger RNA expression of bone morphogenetic protein 6 in human benign and malignant prostatic tissue	1997	University of Sheffield	Cancer	Autzen P Robinson MC Horne CHW
Hamdy FC	Neural network analysis of combined conventional and experimental prognostic markers in prostate cancer: a pilot study	1998	University of Sheffield	Cancer	Naguib RNG Robinson MC Neal DE
Ham J	Stress-activated protein kinases are negatively regulated by cell density	1998	University College London	Cancer	Lallemand D Garbay S Bakiri L
Ham J	Bax promotes neuronal cell death and is downregulated during the development of the nervous system	1997	University College London	Cancer	Vekrellis K McCarthy MJ Watson A
Ham J	Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons	1998	University College London	Cancer	Eilers A Whitfield J Babij C
Ham J	Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons	1998	University College London	Cancer	Watson A Eilers A Lallemand D
Greenwood J	Interleukin-1 beta-induced disruption of the retinal vascular barrier of the central nervous system is mediated through leukocyte recruitment and histamine.	1997	University College London	Cancer	Bamforth SD Lightman SL
Greenwood J	Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells.	2000	University College London	Cancer	Balyasnikova IV Pelligrino DA Adamson P
Greenwood J	Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.	2000	University College London	Cancer	Harkness KA Adamson P Sussman JD
Greenwood J	ICAM-1 coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines.	2000	University College London	Cancer	Etienne-Manneville S Manneville JB Adamson P
Greenman J	Genetic changes in breast cancer detected by comparative genomic hybridisation	2000	University of Hull	Cancer	Loveday RL Simcox D Speirs V
Greenman J	Genetic changes associated with telomerase activity in breast cancer	1999	University of Hull	Cancer	Loveday RL Drew PJ Monson JRT
Greenman J	Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer	1998	University of Hull	Cancer	Kumar H Heer K Lee PWR
Greenman J	Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production	1998	University of Hull	Cancer	O'Hara RJ MacDonald AW Gaskell KM
Gillams A.R.	Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence	1999	University College London	Cancer	Winehouse J Douek M Holz K
Gillams A.R.	Treatment of recurrent colorectal liver metastases by interstitial laser photocoagulation	2000	University College London	Cancer	Shankar A Lees W R Lederman J A
Gillams A.R.	Colorectal liver metastases: alternatives to resection	2000	University College London	Cancer	Taylor I
Gillams A.R.	Survival After Percutaneous, Image-Guided, Thermal Ablation of Hepatic Metastases from Colorectal Cancer	2000	University College London	Cancer	Lees W R
Ganeshaguru K.	Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro	1996	University College London	Cancer	Panayiotidis P Jones D Foroni L
Ganeshaguru K.	Deletion of 13q14.3 and not 13q12 is the most common genetic abnormality detected in chronic lymphocytic leukaemia cells	1997	University College London	Cancer	Panayiotidis P Hoffbrand A V Rowntree C
Ganeshaguru K.	The role of double-stranded RNA-activated protein kinase in human haematological malignancies	1997	University College London	Cancer	Basu S Panayiotidis P Hart S M
Ganeshaguru K.	Expression of the human major vault protein LRP in acute myeloid leukemia	1997	University College London	Cancer	Hart S M Scheper R J Prentice H G
Futter CE	In polarized MDCK cells basolateral vesicles arise from clathrin-gamma-adaptin-coated domains on endosomal tubules.	1998	University College London	Cancer	Gibson A Allchin EH Maxwell S
Futter CE	The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3.	1998	University College London	Cancer	Nagata K Puls A Aspenstrom P
Futter CE	Sorting mechanisms regulating membrane protein traffic in the apical transcytotic pathway of polarized MDCK cells.	1998	University College London	Cancer	Gibson A Maxwell S Allchin EH
Futter CE	Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes.	1996	University College London	Cancer	Pearse A Hewlett LJ Hopkins CR
Freeman A.A.	The minichromosome maintenance proteins as biological markers of dysplasia and malignancy	1999	University College London	Cancer	Morris L S Mills A Stoeber K
Freeman A.A.	Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine	1999	University College London	Cancer	Stoeber K Halsall I Swinn R
Farndon JR	Changes in cytoplasmic calcium determine the secretory response to extracellular cations in human parathyroid cells: a confocal microscopy study using FM1-43 dye	2000	University of Bristol	Cancer	Mihai,R Whitmarsh-Everiss,TW Schofield,JG
Farndon JR	Thimerosal increases the responsiveness of the calcium receptor in human parathyroid and rMTC6-23 cells	1999	University of Bristol	Cancer	Mihai,R Whitmarsh-Everiss,TW Schofield,JG
Farndon JR	C2-ceramide increases cytoplasmic calcium concentrations in human parathyroid cells	2000	University of Bristol	Cancer	Mihai,R Whitmarsh-Everiss,TW Schofield,JG
Farndon JR	A prospective longitudinal study examining quality of life in patients with esophageal cancer	2000	University of Bristol	Cancer	Blazeby,JM Donovan,JL Alderson,D
Emberton M.	A virtual reality TURP simulator	1999	University College London	Cancer	Ballaro J Briggs T Garcia Montes F
Davies ANT	Transdermal fentanyl and the opioid withdrawl syndrome.	1996	University of Bristol	Cancer	Bond,C
Davies ANT	A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer.	1998	University of Bristol	Cancer	Daniels,C Pugh,R Sharma,K
Davies ANT	A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer	2000	University of Bristol	Cancer
Davies ANT	Diminished effects of transdermal fentanyl in the terminal phase?	1997	University of Bristol	Cancer	Prentice,W
Crow J.C.	Ovarian intraepithelial dysplasia in relation to ovalulation patterns	1999	University College London	Cancer	Rolfe K J Nieto J J Sundaresan M
Crow J.C.	Comparison of accuracy of scintimammography and x-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy	1998	University College London	Cancer	Cwikla J B Buscombe J R Kelleher S M
Crow J.C.	Use of 99Tcm-MIBA in the assessment of patients with suspected recurrent breast cancer	1998	University College London	Cancer	Cwikla J B Buscombe J R Parbhoo S P
Crow J.C.	Sex cord-stromal tumours of the ovary - a 25 year review	1997	University College London	Cancer	Aboud E Gordon H
Croucher PI	The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway	1998	University of Sheffield	Cancer	Shipman CM Russell RGG Helfrich MH
Croucher PI	Human myeloma cells promote the recruitment of osteoblast prescursors: Mediation by interleukin-6 receptor	2000	University of Sheffield	Cancer	Karadag A Scutt AM
Corfield AP	A study of the intracellular and secreted forms fo the MUC2 mucin from the PC/AA intestinal cell line.	1999	University of Bristol	Cancer	Aksoy,N Thornton,DJ Paraskeva,C
Corfield AP	Biosynthesis of MUC2 mucin: evidence for a slow assembly of fully glycosylated units.	1996	University of Bristol	Cancer	Sheehan,JK Thornton,DJ Howard,M
Corfield AP	Mucin gene expression in Barrett's oesophagus.	2000	University of Bristol	Cancer	Arul,GS Moorghen,M Myerscough,N
Corfield AP	Co-ordinated expression of Mucin and Trefoil peptide genes in the ulcer associated cell lineage and the gastrointestinal mucosa.	2000	University of Bristol	Cancer	Longman,RJ Douthwaite,JA Sylvester,PA
Coleman RE	Clinical course and prognostic factors following bone recurrence from breast cancer	1998	University of Sheffield	Cancer	Smith P Rubens RD
Coleman RE	Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion	1999	University of Sheffield	Cancer	Vinholes J Lacombe D Rose C
Coleman RE	Metabolic effects of pamidronate in patients with metastatic bone disease	1996	University of Sheffield	Cancer	Vinholes J Purohit OP Eastell RE
Coleman RE	Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy	1997	University of Sheffield	Cancer	Eastell RE Guo CY Purohit OP
Coakham HB	Intraoperative monitoring during surgery for acoustic neuroma: benefits of an extratympanic intrameatal electrode	1999	University of Bristol	Cancer	Mullatti,N Maw,AR Bulter,SR
Coakham HB	Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies	1998	University of Bristol	Cancer	Kemshead,JT Hopkins,KI Pizer,B
Coakham HB	Treatment of neoplastic meningitis by targeted radiation using (131)I-radiolabelled monoclonal antibodies. Results of responses and long term follow-up in 40 patients	1998	University of Bristol	Cancer	Kemshead,JT
Coakham HB	Central nervous system metastasis in Wilms' tumour: a review of three consecutive United Kingdom trials	1998	University of Bristol	Cancer	Lowis,SP Foot,ABM Gerrard,MP
Chessells JM	Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukaemia in first remission: results from Medical Research Council UKALL X and XI	2000	University College London	Cancer	Wheeler KA Richards SM Bailey CC
Chessells JM	Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia	2000	University College London	Cancer	Arico M Valsecchi MG Camitta B
Chessells JM	Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia - the MRC UKALL X experience	1998	University College London	Cancer	Wheeler K Richards S Bailey C
Chessells JM	Anthracycline dose in childhood acute lymphoblastic leukaemia: Issues of early survival versus late cardiotoxicity	1997	University College London	Cancer	Sorensen K Levitt G Bull C
Cawkwell L	Frequency of replication errors in colorectal cancer and their association with family history	1998	University of Hull	Cancer	Brown SR Finan PJ Quirke P
Cawkwell L	A comparison of microsatellite instability in early onset gastric carcinomas from relatively low and high incidences European populations	2000	University of Hull	Cancer	Hayden JD Dixon MF Pardal F
Cawkwell L	Defective hMSH2/hMLH1 protein expression is seen in frequently in ulcerative colitis associated colorectal cancers	2000	University of Hull	Cancer	Sutherland F Murgatroyd H Jarvis P
Cawkwell L	Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defect mis-match repair	1999	University of Hull	Cancer	Gray S Murgatroyd H Sutherland F
Carnero A	p16(INK4A) and p19(ARF) act in overlapping pathways in cellular immortalization	2000	University College London	Cancer	Hudson JD Price CM Beach DH
Carnero A	MaRX: an approach to genetics in mammalian cells	1999	University College London	Cancer	Hannon GJ Sun P Xie L
Carnero A	A proinflammatory cytokine inhibits p53 tumor suppressor activity	1999	University College London	Cancer	Hudson JD Shoabi M Maestro R
Carnero A	Rho proteins induce metastatic properties in vivo	1997	University College London	Cancer	del Peso L Hernandez-Alcoceba R Embade N
Brown NJ	Studies on gastric mucosal microcirculation. 1. The nature of regional variations induced by ethanol injury	1997	University of Sheffield	Cancer	N Kalia Jacob S Reed MWR
Brown NJ	Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro	1998	University of Sheffield	Cancer	Wyld L Reed MWR Smith O
Brown NJ	Trafficking of 'immune' CD4(+)/CD8(+) T-lymphocytes into the RENCA tumour microcirculation in vivo in mice	2000	University of Sheffield	Cancer	Ali SA Goepel JR Anderson DQ
Brown NJ	An evaluation of linear model analysis techniques for processing images of microcirculation activity	1998	University of Sheffield	Cancer	Mayhew J Hu DW Zheng Y
Brickell PM	Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons	1996	University College London	Cancer	Reissmann E Ernsberger U Francis West PH
Brickell PM	Loss of heterozygosity and microsatellite instability at the MLL locus are common in childhood acute leukemia, but not in infant acute leukemia	1999	University College London	Cancer	Webb JC Golovleva I Simpkins AH
Brickell PM	Activation of Fgf-4 and HoxD gene expression by BMP-2 expressing cells in the developing chick limb	1996	University College London	Cancer	Duprez DM Kostakopoulou K Francis-West PH
Brickell PM	Lateral and axial signals involved in avian somite patterning: a role for BMP-4	1996	University College London	Cancer	Pourquie O Fan CM Coltey M
Brady HJM	Bax alpha perturbs T-cell development and affects cell cycle entry of T-cells	1996	University College London	Cancer	Gil-Gomez G Kirberg J Berns A
Brady HJM	The action of Bax and Bcl-2 on T cell selection	1998	University College London	Cancer	Williams O Norton T Halligey M
Brady HJM	A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis	1998	University College London	Cancer	GilGomez G Berns A
Brady HJM	Bad can act as a key regulator of T cell apoptosis and T cell development	1999	University College London	Cancer	Mok CL GilGomez G Williams O
Blazeby JM	Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer	1996	University of Bristol	Cancer	Alderson,D Winstone,K Steyn,R
Blazeby JM	Chemotherapy, irradiation and their roles in the management of oesophageal cancer	1997	University of Bristol	Cancer	Alderson,D
Blazeby JM	Selective cholangiography with laparoscopic cholecystectomy: Review of a protocol	1996	University of Bristol	Cancer	Galloway,SW Tulloh,BR Poskitt,KR
Blazeby JM	Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer	1998	University of Bristol	Cancer	Wils,J Sahmoud,T Sobrero,A
Beach D	cdc25 cell cycle phosphatase as a target of c-myc.	1996	University College London	Cancer	Galaktionov K Chen XC
Beach D	Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a	1997	University College London	Cancer	Serrano B Lin AW McCurrach ME
Beach D	An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells	2000	University College London	Cancer	Hammond SM Bernstein E Hannon GJ
Beach D	p-53 independent function of MDM2 in TGF-beta1 resistance	1998	University College London	Cancer	Sun P Dong P Dai K
Balda MS	The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression.	2000	University College London	Cancer	Matter K
Balda MS	The SH3 domain of the tight junction protein ZO-1 binds to a serine protein kinase that phosphorylates a region C-terminal to this domain.	1996	University College London	Cancer	Anderson JM Matter K
Balda MS	Biogenesis of tight junctions: the C-terminal domain of occludin mediates basolateral targeting.	1998	University College London	Cancer	Matter K
Balda MS	Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein.	1996	University College London	Cancer	Whitney JA Flores C Gonzalez S
Bailly M	Role of cofilin in EGF stimulated actin polymerization in mammary adenocarcinoma cells.	2000	University College London	Cancer	Chan AY Zebda N Segall JE
Bailly M	Phosphorylation of ADF/Cofilin abolishes EGF-induced actin nucleation at the leading edge and subsequent lamellipod extension.	2000	University College London	Cancer	Zebda N Bernard O Welti S
Bailly M	Relationship between Arp2/3 complex and the barbed ends of actin filaments at the leading edge of carcinoma cells after epidermal growth factor stimulation.	1999	University College London	Cancer	Macaluso F Cammer M Chan A
Bailly M	Epidermal growth factor receptor distribution during chemotactic responses.	2000	University College London	Cancer	Wyckoff J Bouzahzah B Hammerman R
Atkin SL	Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients	1999	University of Hull	Cancer	Speirs V Malone C Walton DS
Atkin SL	Coexpression of estrogen receptor alpha and beta: Poor prognostic factors in human breast cancer?	1999	University of Hull	Cancer	Speirs V Parkes AT Kerin MH
Atkin SL	Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast cancers	1999	University of Hull	Cancer	Speirs V
Atkin SL	In-vivo and in-vitro expression of steroid converting enzymes in human breast tumours: associations with interleukin-6	1999	University of Hull	Cancer	Speirs V Walton DS Hall MC
Anderson WJ	Amplification of the t(2; 13) and t(1; 13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction	1997	University College London	Cancer	Renshaw J McManus A Carter R
Anderson WJ	A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma.	2000	University College London	Cancer	Gordon T Brinkschmidt C Coleman N
Anderson WJ	Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma	1996	University College London	Cancer	Weber-Hall S McManus A Nojima T
Anderson WJ	Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization	1996	University College London	Cancer	Weber-Hall S McManus A Abe S
Alderson D	Oesophageal cancer staging using endoscopic ultrasonography	1998	University of Bristol	Cancer	Vickers,J
Alderson D	Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma	1998	University of Bristol	Cancer	Morgan,RJ Newcomb,PV Bailey,M
Alderson D	Diffuse oesophageal spasm: diagnosis by ambulatory 24 hour manometry	1997	University of Bristol	Cancer	Barham,CP Gotley,DC Fowler,A
Alderson D	Prospective comparison of EUS and ERCP in the detection of bile duct stones	1997	University of Bristol	Cancer	Norton,SA
Adamson P	Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway.	1999	University College London	Cancer	Etienne S Couraud PO Calder V
Adamson P	Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system.	2000	University College London	Cancer	Romero IA Prevost MC Perret E
Adamson P	Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways.	1997	University College London	Cancer	Cazaubon S Chaverot N Romero IA
Adamson P	ICAM-1-signaling pathways asssociated with Rho activation in microvascular brain endothelial cells.	1998	University College London	Cancer	Etienne S Greenwood J Strosberg AD
Vigushin D M	Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer	1998	Imperial College of Science, Technology	Cancer - Cancer Therapy	Poon GK Boddy A Coombes RC
Vigushin D M	Identification and characterization of limonene metabolites in patients with advanced cancer by liquid chromatography/mass spectrometry	1996	Imperial College of Science, Technology	Cancer - Cancer Therapy	Poon GK Griggs LJ Coombes RC
Vigushin D M	Echocardiographic assessment of cardiac involvement in systemic AL amyloidosis in relation to whole body amyloid load measured by serum amyloid P component (SAP) clearance	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Clesham GJ Pepys MB Nihoyannopoulos P
Vigushin D M	Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Udom DI Linardou H Coombes RC
Stewart J S	Influence of tumour size on uptake of (111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Harrington KJ Rowlinson-Busza G Peters AM
Stewart J S	Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Ranson MR Carmichael J OByrne K
Stewart J S	Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Harrington KJ Rowlinson-Busza G Vile RG
Stewart J S	Biodistribution and pharmacokinetics of (111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Harrington KJ Rowlinson-Busza G Syrigos KN
Price P M	Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa	1999	Imperial College of Science, Technology	Cancer - Cancer Therapy	Harte RJA Luthra SJ Jones T
Price P M	Studies on the metabolism of the novel antitumor agent [N-methyl-C- 11]N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Osman S Luthra SK Jones T
Lemoine N R	Insulation of a conditionally expressed transgene in an adenoviral vector	1999	Imperial College of Science, Technology	Cancer - Cancer Therapy	Vassaux G Hurst HC
Lemoine N R	Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Ring CJ Blouin P Martin LA
Lemoine N R	Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer	1998	Imperial College of Science, Technology	Cancer - Cancer Therapy	Taniguchi T Kakkar AK Tuddenham EG
Lemoine N R	Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression	1999	Imperial College of Science, Technology	Cancer - Cancer Therapy	Pandha HS Rigg A Hurst HC
Kirn D	An adenovirus E1A mutant that demonstrates potent and selective anti-tumoral efficacy	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Heise C Hermiston T Hawkins L
Kirn D	ONYX-015, an E1B gene-attenuated adenovirus, causes tumor- specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Heise C SampsonJohannes A Williams A
Kirn D	In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Rogulski KR Freytag SO Zhang K
Kirn D	A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Khuri FR Nemunaitis J Ganly I
Jones B	Radiobiologically based assessments of the net costs of fractionated radiotherapy	1996	Imperial College of Science, Technology	Cancer - Cancer Therapy	Dale RG
Jones B	The reduction of tumour control with increasing overall time: Mathematical considerations	1996	Imperial College of Science, Technology	Cancer - Cancer Therapy	Dale RG
Jones B	Inclusion of molecular biotherapies with radical radiotherapy: Modeling of combined modality treatment schedules	1999	Imperial College of Science, Technology	Cancer - Cancer Therapy	Dale RG
Jones B	Biological equivalent dose assessment of the consequences of hypofractionated radiotherapy	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Dale RG Khaksar SJ
Dale R	Calculation of integrated biological response in brachytherapy	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Coles IP Deehan C ODonoghue JA
Dale R	The assessment of RBE effects using the concept of biologically effective dose	1999	Imperial College of Science, Technology	Cancer - Cancer Therapy	Jones B
Dale R	Bed-time charts and their application to the problems of interruptions in external beam radiotherapy treatments	1999	Imperial College of Science, Technology	Cancer - Cancer Therapy	Sinclair JA Oates JP
Dale R	Radiobiological prediction of normal tissue toxicities and tumour response in the radiotherapy of advanced non-small-cell lung cancer	1998	Imperial College of Science, Technology	Cancer - Cancer Therapy	Singer JM Price P
Aboagye E O	Detection of tumor response to chemotherapy by 1H nuclear magnetic resonance spectroscopy: effect of 5-fluorouracil on lactate levels in radiation-induced fibrosarcoma 1 tumors	1998	Imperial College of Science, Technology	Cancer - Cancer Therapy	Shungu DC Glickson JD Bhujwalla ZM
Aboagye E O	Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in-vivo imaging of drug action	2000	Imperial College of Science, Technology	Cancer - Cancer Therapy	Saleem A Yap J Price PM
Aboagye E O	Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia	1997	Imperial College of Science, Technology	Cancer - Cancer Therapy	Maxwell RJ Workman P Griffiths JR
Aboagye E O	Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging	1998	Imperial College of Science, Technology	Cancer - Cancer Therapy	Artemov D Senter PD Bhujwalla ZM
Rockall T A	Carcinoembryonic antigen: its value in the follow up of patients with colorectal cancer	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	McDonald PJ
Rockall T A	Risk assessment after acute upper gastrointestinal haemorrhage	1996	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Logan RFA Devlin HB Northfield TC
Rockall T A	Selection of patients for early discharge or outpatient care after acute upper gastrointestinal haemorrhage	1996	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Logan RFA Devlin HB Northfield TC
Rockall T A	Influencing the practice and outcome in acute upper gastrointestinal haemorrhage	1997	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Logan RFA Devlin HB Northfield TC
Phillips R K	Double-blind randomised controlled trial of effect of metronidazole on pain after day-case haemorrhoidectomy	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Carapeti EA Kamm MA McDonald PJ
Phillips R K	The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudsons 'two-hit' hypothesis	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Lamlum H Ilyas M Clark SK
Phillips R K	Screening SMAD1, SMAD2, SMAD3, and SMAD5 for germline mutations in juvenile polyposis syndrome	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Bevan S Woodford-Richens K Rozen P
Phillips R K	The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis	2000	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Steinbach G Lynch PM Wallace MH
Northover J M	Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Lunniss PJ Skinner S Britton KE
Northover J M	Inherited susceptibility to colorectal adenomas and carcinomas: Evidence for a new predisposition gene on 15q14-q22	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Tomlinson I Rahman N Frayling I
Northover J M	Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Verne JECW Aubrey R Love SB
Northover J M	Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5- fluorouracil, and mitomycin	1996	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Arnott SJ Cunningham D Gray R
Kakkar A K	Urokinase receptor is a key player in tumour progression	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Taniguchi T Lemoine NR
Kakkar A K	Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Chinswangwatanakul V Lemoine NR Williamson RCN
Kakkar A K	Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Taniguchi T Tuddenham EG Lemoine NR
Kakkar A K	Evolution of genetic abnormalities in hepatocellular carcinomas demonstrated by DNA fingerprinting	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Sirivatanauksorn Y Williamson RCN Lemoine NR
Halligan S	Evacuation proctography: A prospective study of diagnostic and therapeutic effects	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Harvey CJ Bartram CI Hollings N
Halligan S	MR imaging of fistula in ano: Are endoanal coils the gold standard?	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Bartram CI
Halligan S	Changes in anal anatomy following vaginal delivery revealed by anal endosonography	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Frudinger A Bartram CI Kamm MA
Halligan S	Prospective assessment of accuracy of endoanal MR imaging and endosonography in patients with fecal incontinence	2000	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Malouf AJ Bartram CI Kamm MA
Habib N	Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression	1997	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Mitry RR Sarraf CE Pignatelli M
Habib N	Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment	2000	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Mitry RR Sarraf CE Havlik R
Habib N	The effect of mechanically enhancing portal venous inflow on hepatic oxygenation, microcirculation, and function in a rabbit model with extensive hepatic fibrosis	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Jiao LR Seifalian AM Davidson BR
Habib N	A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours	1999	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Hodgson HJF Lemoine N Pignatelli M
Atkin W S	Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Hart A Edwards R Northover JMA
Atkin W S	Circulating insulin-like growth factor II and colorectal adenomas	2000	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Renehan AG Painter JE O'Halloran D
Atkin W S	Single blind, randomised trial of efficacy and acceptability of oral Picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening	2000	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Hart A McIntyre P Northover JMA
Atkin W S	Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Hart AR Kudo S Mackay EH
Andreyev H J	K-ras mutations in patients with early colorectal cancers	1997	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Tilsed JVT Cunningham D Clarke PA
Andreyev H J	Joint symptoms after restorative proctocolectomy in ulcerative colitis and familial polyposis coli	1996	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Kamm MA Forbes A Nicholls RJ
Andreyev H J	Kirsten ras mutations in patients with colorectal cancer: the multicenter RASCAL study	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Norman AR Cunningham D Oates JR
Andreyev H J	Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Norman AR Oates J Cunningham D
Allen-Mersh T G	Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases	1996	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Earlam S Glover C Fordy C
Allen-Mersh T G	Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases	1998	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Durand-Zaleski I Earlam S Fordy C
Allen-Mersh T G	Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients	1997	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Earlam S Glover C Fordy C
Allen-Mersh T G	Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases	1997	Imperial College of Science, Technology	Cancer - Colorectal + Gastrointestinal Cancer	Durand-Zaleski I Roche B Buyse M
Waxman J	Second messenger up-regulation of androgen receptor gene transcription is absent in androgen insensitive human prostatic carcinoma cell lines, PC-3 and DU-145	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Stubbs AP Lalani EN Stamp GWH
Waxman J	Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Rajkumar T Stamp GWH Gullick WJ
Waxman J	Altered gamma-catenin expression correlates with poor survival in patients with bladder cancer	1998	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Syrigos KN Harrington K Pignatelli M
Waxman J	Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Papamichael D Gallagher CJ Oliver RTD
Soutter W P	Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Lopes AD Fletcher A Monaghan JM
Soutter W P	Is needle diathermy excision of the transformation zone a better treatment for cervical intraepithelial neoplasia than large loop excision?	1999	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Basu PS Darcy T McIndoe A
Soutter W P	Stage I cervical cancer: Tumor volume by magnetic resonance imaging of screen-detected versus symptomatic lesions	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	DeSouza NM McIndoe GA Krausz T
Soutter W P	E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Wilding J Vousden KH Pignatelli M
Seckl M	Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix	1999	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Mulholland PJ Bishop AE Hales CN
Seckl M	Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic plac	2000	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Newlands ES Mulholland PJ Rustin GJS
Seckl M	[D-Arg(1),D-Trp(5,7,9),Leu(11)]Substance P: A novel potent inhibitor of signal transduction and growth in vitro and in vivo in small cell lung cancer cells	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Higgins T Widmer F Rozengurt E
Seckl M	[D-Arg1,D-Trp5,7,9,Leu11]Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cells	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Higgins T Rozengurt E
Newlands E S	Surveillance policy for stage I ovarian germ cell tumors	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Dark GG Bower M Rustin GJS
Newlands E S	Phase I trial of temozolomide using an extended continuous oral schedule	1998	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Brock CS Bower M Rustin GJS
Newlands E S	EMA/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Bower M Holden L Bagshawe KD
Newlands E S	Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Rustin GJS Lutz JM Bagshawe KD
Lalani E M	MUC1 expressed in PanC1 cells decreases adhesion to type 1 collagen but increases contraction in collagen lattices	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Hudson MJH Stamp GWH Hollingsworth MA
Lalani E M	Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Laniado ME Fraser SP Abel PD
Lalani E M	Role for transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Nanji AA Tahan SR Golding M
Lalani E M	Differentially expressed genes in hormone refractory prostate cancer - Association with chromosomal regions involved with genetic aberrations	1999	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Stubbs AP Abel PD Golding M
Healy J	Dynamic MR Imaging of the pelvic floor in asymptomatic subjects	2000	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Goh V Halligan S Bartram C
Healy J	Fibroid embolisation: a technique not without significant complications	2000	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Vashisht A McCall J Burn P R
Healy J	Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries	2000	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Burn P R Chinn R J Vashisht A
Healy J	Magnetic resonance imaging of fistula-in-ano: STIR or SPIR?	1998	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Halligan S Bartram C I
De Souza N M	High-resolution MR imaging of stage I cervical neoplasia with a dedicated transvaginal coil: MR features and correlation of imaging and pathologic findings	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Krausz T Gilderdale DJ Soutter WP
De Souza N M	Laser ablation of the endometrium: MR appearance during and after treatment and the relation of MR appearance to clinical outcome	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	McMillan DL Harris DNF Young IR
De Souza N M	Magnetic resonance imaging of the primary site in stage I cervical carcinoma: A comparison of endovaginal coil with external phased array coil techniques at 0.5T	2000	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Gilderdale DJ McIndoe GA Soutter WP
De Souza N M	Fecal incontinence in scleroderma: Assessment of the anal sphincter with thin-section endoanal MR imaging	1998	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Williams AD Gilderdale DJ Black CM
Borysiewicz L K	A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Fiander A Nimako M Inglis SC
Borysiewicz L K	Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Evans EML Man S Evans AS
Bevan C	The role of coactivators in steroid hormone action	1999	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Parker M
Bevan C	The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1	1999	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Hoare S Heery DM Parker MG
Bevan C	Functional analysis of six androgen receptor mutations identified in patients with partial androgen insensitivity syndrome	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Brown BB Davies HR Patterson MN
Bevan C	Wide variation in androgen receptor dysfunction in complete androgen insensitivity syndrome	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Hughes IA Patterson MN
Abel P D	Impact of surgery for stress incontinence on the social lives of women	1998	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Black NA Bowling A Griffiths JM
Abel P D	Impact of surgery for stress incontinence on morbidity: cohort study	1997	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Black N Griffiths J Bowling A
Abel P D	Decreased HLA-A expression in prostate cancer is associated with normal allele dosage in the majority of cases	2000	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Lu QL Mitchell S Lalani EN
Abel P D	Sociodemographic and symptomatic characteristics of women undergoing stress incontinence surgery in the UK	1996	Imperial College of Science, Technology	Cancer - Gynae. Trophoblastic + Prostate Cancer	Black NA Griffiths JM Bowling A
Stevenson FK	DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	King, CA Spellerberg, MB Zhu, D
Stevenson FK	VH and VL gene analysis in sporadic Burkitt's lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection	1996	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Chapman, CJ Zhou, JX Rickinson, AB
Stevenson FK	Differential rates of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Oscier, D Thompsett, A Zhu, D
Stevenson FK	DNA vaccines against lymphoma: Promotion of anti-idiotypic antibody responses induced by single chain FV genes by fusion to tetanus toxin fragment C	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Spellerberg, MB Zhu, D King, CA
Potter NK	Anti-idiotypic antibody D12 and superantigen SPA both interact with human VH3-encoded antibodies on the external face of the heavy chain involving FR1,CDR2 and FR3	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Li, Y Capra, JD Mageed, RA
Potter NK	Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Wilson, PC Pascual, V Capra, JD
Potter NK	Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs	1996	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Li, Y Capra, JD
Potter NK	The I binding specificity of human VH4-34 (VH4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3	1996	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Li, Y Spellerberg, MB Stevenson, FK
Hamblin TJ	International scoring system for evaluating prognosis in myelodysplastic syndromes	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Greenberg, P Cox, C LeBeau, MM
Hamblin TJ	Insight into the origin and clonal history of B-cell tumors as revealed by analysis of immunoglobulin variable region genes	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Sahota, S Zhu, D Ottensmeier, C
Hamblin TJ	Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Sahota, S Leo, R Stevenson, FK
Hamblin TJ	Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia	1999	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Davis, Z Gardiner, A Oscier, D
Glennie MJ	HLA Class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor	1996	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Elsasser, D Valerius, T Repp, R
Glennie MJ	CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help	1999	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	French, R Chan, C Tutt, AL
Glennie MJ	Internalization of the lymphocytic surface protein CD22 is controlled by a novel membrane proximal cytoplasmic motif	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Chan, C Wang, J French, RR
Glennie MJ	Therapeutic efficacy of FcgRI/CD64-directed bispecific antibodies in B-cell lymphoma	2000	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Honeychurch, J Tutt, A Valerius, T
Flavell DJ	Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Flavell, SU Warnes, S Noss, A
Flavell DJ	Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Flavell, SU Noss, A Boehm, DA
Flavell DJ	Systemic Therapy with 3BIT, a triple combination cocktail of anti-CD19, -CD22, and -CD38-saporin immunotoxins, is curative of human B-cell lymphoma in severe combined immunodeficient mice	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Flavell, SU Noss, A Pulford, KAF
Flavell DJ	Anti-CD7 antibody and immunotoxin treatment of human CD7+ T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice	2000	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Flavell, SU Warnes, S Noss, A
Elliott TJ	Crystal structures of two H-2Db/glycopeptide complexes suggest a molecular basis for CTL cross-reactivity	1999	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Glithero, A Tormo, J Haurum, JS
Elliott TJ	Presentation of cytosolic glycosylated peptides by human Class I major histocompatibility complex molecules in vivo	1999	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Haurum, JS Bjerring Hoier, I Arsequell, G
Al-Shamkhani A	OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand	1996	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Birkeland, ML Puklavec, M James, W
Al-Shamkhani A	Expression of the H52 epitope on the beta2 subunit is dependent on its interaction with the alpha subunits of the leukocyte integrins LFA-1, Mac-1 and p150,95 and the presence of Ca2+	1998	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Law, SKA
Al-Shamkhani A	Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells	1997	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Mallett, S Brown, MH James, W
Al-Shamkhani A	Effect of integrin beta2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression and function	2000	University of Southampton	Cancer Sciences - Immunology and Immunotherapy	Tan, S-M Hyland, RH Douglass, WA
Thomas EJ	Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Obata, K Morland, SJ Watson, RH
Thomas EJ	Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Jiang, X Morland, SJ Hitchcock, A
Thomas EJ	Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Morland, SJ Jiang, X Hitchcock, A
Thomas EJ	Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci	1996	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Jiang, X Hitchcock, A Bryan, EJ
Sahota SS	Ig VH gene mutational patterns indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance	1996	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Leo, R Hamblin, TJ Stevenson, FK
Sahota SS	VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytoid B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Garand, R Bataille, R Smith, AJ
Sahota SS	VH gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events	1999	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Garand, R Mahroof, R Smith, AJ
Sahota SS	Somatic mutation of bcl-6 genes can occur in the absence of VH mutations in chronic lymphocytic leukemia	2000	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Davis, Z Hamblin, TJ Stevenson, FK
Packham GK	BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Brimmell, M Mendiola, R Mangion, J
Packham GK	Identification of a novel human Bcl-X promoter and exon	2000	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	MacCarthy-Morrogh, L Wood, L Brimmell, M
Packham GK	Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis and microtubule assembly in human breast cancer cells	2000	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	MacCarthy-Morrogh, L Townsend, PA Purohit, A
Packham GK	Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	White, EL Eischen, CM Yang, H
Oscier D	Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Corcoran, MM Rasool, O Liu, Y
Oscier D	Cloning of two candidate tumor suppressor genes within a 10kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia	1997	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Liu, Y Corcoran, M Rasool, O
Oscier D	Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations	1999	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Corcoran, MM Mould, SJ Ibbotson, RE
Oscier D	Molecular cytogenetic analysis in splenic lymphoma with villous lymphocytes: frequent allelic imbalance of the RB1 gene but not the D13S25 locus on chromosome 13q14	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Garcia-Marco, JA Nouel, A Navarro, B
Eccles DM	Segregation analysis of ovarian cancer using diathesis to include other cancers	1997	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Forabosco, P Williams, A Dunn, B
Eccles DM	Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene	1996	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	van der Luijt, R Breukel, C Bullman, H
Eccles DM	Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome	1997	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Marsh, DJ Roth, S Lunetta, KL
Eccles DM	Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Houlston, R Bevan, S Williams, A
Blaydes JP	DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Hupp, TR
Blaydes JP	Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways	2000	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Craig, AL Gibbs, NK Hupp, TR
Blaydes JP	Tolerance of high levels of wild-type p53 in transformed epithelial cells dependent on auto-regulation by mdm-2	1997	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Gire, V Rowson, JM Wynford-Thomas, D
Blaydes JP	The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2	1998	University of Southampton	Cancer Sciences - Molecular Mechanisms in Cancer	Wynford-Thomas, D
Primrose JN	Bombesin family receptor and ligand gene expression in human colorectal cancer and normal mucosa	2000	University of Southampton	Cancer Sciences - Systemic Therapy	Chave, HS, Gough, AC Palmer, K
Primrose JN	A prospective randomised controlled study of the use of ranitidine in patients with gastric cancer	1998	University of Southampton	Cancer Sciences - Systemic Therapy	Miller, GV Preston, SR Gokhale, J
Primrose JN	Obstructive jaundice causes reduced expression of polymorphonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro	1996	University of Southampton	Cancer Sciences - Systemic Therapy	Plusa, S Webster N
Primrose JN	Marimastat in recurrent colorectal cancer: exploratory evaluation of biological activity by measurement of carcinoembryonic antigen	1999	University of Southampton	Cancer Sciences - Systemic Therapy	Bleiberg, H Daniel, F Van Belle, S
Ottensmeier CH	Isotype switch variants reveal clonally related subpopulations in diffuse large B-cell lymphoma	2000	University of Southampton	Cancer Sciences - Systemic Therapy	Stevenson, FK
Ottensmeier CH	Absence of constitutive EGF receptor activation in ovarian cancer cell lines	1996	University of Southampton	Cancer Sciences - Systemic Therapy	Swanson, L Strobel, T Druker, B
Ottensmeier CH	Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression	1998	University of Southampton	Cancer Sciences - Systemic Therapy	Thompsett, AR Zhu, D Wilkins, BS
Ottensmeier CH	Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients	1999	University of Southampton	Cancer Sciences - Systemic Therapy	Pelosi, G Pasini, F Pavanel, F
Mead GM	Impact of the treating institution on survival of patients with poor-prognosis metastatic nonseminoma	1999	University of Southampton	Cancer Sciences - Systemic Therapy	Collett, L Sylvester, RJ Stenning, SP
Mead GM	Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial	1999	University of Southampton	Cancer Sciences - Systemic Therapy	Hall, RR Roberts, JT
Mead GM	International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers	1997	University of Southampton	Cancer Sciences - Systemic Therapy	Stenning, SP Cook, P Fossa, SD
Mead GM	Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: A randomized Medical Research Council/European Organization for Research and Treatment of Cancer	1998	University of Southampton	Cancer Sciences - Systemic Therapy	Kaye, SB Fossa, S Cullen, M
Johnson P	Clinical trials of antibody therapy	2000	University of Southampton	Cancer Sciences - Systemic Therapy	Glennie, M
Johnson P	Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma	1999	University of Southampton	Cancer Sciences - Systemic Therapy	Apostolidis, J Foran, JM Norton, A
Johnson P	Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study	1998	University of Southampton	Cancer Sciences - Systemic Therapy	Coiffier, B Haioun, C Ketterer, N
Johnson P	European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma	2000	University of Southampton	Cancer Sciences - Systemic Therapy	Foran, JM Rohatiner, AZS Cunningham, D
Illidge TM	Release of mitotic descendants by giant cells from irradiated Burkitt's lymphoma cell lines	2000	University of Southampton	Cancer Sciences - Systemic Therapy	Erenpreisa, JA Cragg, MS Fringes, B
Illidge TM	Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage	2000	University of Southampton	Cancer Sciences - Systemic Therapy	Cragg, MS Fringes, B Olive, P
Illidge TM	The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma	1999	University of Southampton	Cancer Sciences - Systemic Therapy	Cragg, MS McBride, HM French, RR
Illidge TM	Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors	1998	University of Southampton	Cancer Sciences - Systemic Therapy	Tutt, AL French, RR Honeychurch, J
ZHANG L	PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium	1998	University of Oxford	Cancer Studies	Zhao Y Hague S Rees CPM
ZHANG L	Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density	2000	University of Oxford	Cancer Studies	Hague S Oehler MK Rees MC
Yin J	Expression of AML1/MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21).	1997	University of Manchester	Cancer Studies	Saunders,M.J. Brereton,M.L. Adams,J.A.
Yin J	The in vitro effect of pegylated recombinant human megakaryocyte growth and development (PEGrHuMDGF) on megakaryopoiesis in patients with aplastic anaemia.	1999	University of Manchester	Cancer Studies	Brereton,M.L. Adams,J.A. Briggs,M.
Yin J	P-glycoprotein and multidrug resistance-associated protein, but not lung-resistance protein, lower the intracellular Daunorubicin accumulation in acute myeloid leukaemic cells.	2000	University of Manchester	Cancer Studies	Borg,A.G. Burgess,R. Green,L.M.
Yin J	Molecular quantitation of minimal residual disease in acute myeloid leukaemia with t(8;21) can identify patients in durable remission and predict clinical relapse.	2000	University of Manchester	Cancer Studies	Tobal,K. Newton,J. Macheta,M.
Woodman CBJ	Survival rates from interval cancer in NHS breast screening programme.	1998	University of Manchester	Cancer Studies	Collins,S Threlfall,A Prior,P
Woodman CBJ	Cost effectiveness of shortening the screening interval or extending age range of NHS breast screening programme: computer simulation study.	1998	University of Manchester	Cancer Studies	Boer,R De Koning,H Threlfall,A
Woodman CBJ	NHS Breast Screening Programme: is the high incidence of interval cancers inevitable?	1996	University of Manchester	Cancer Studies	Ashbury,D Boggis,C R M Sheals,D
Woodman CBJ	Human Papillomavirus infection and risk of progression of epithelial abnormalities of the cervix.	1996	University of Manchester	Cancer Studies	Rollason,T Ellis,J Tiernay,R
Winton D.	Analysis of DNA damage and repair accompanying differentiation in the intestinal crypt	1998	University of Cambridge	Cancer Studies	Brooks R.A.
Winton D.	Determination of spatial patterns of DNA damage and repair in intestinal crypts by multi-gel electrophoresis	1996	University of Cambridge	Cancer Studies	Brooks R.A.
Winton D.	p53 mutation frequency and apoptosis in the murine small intestine	1997	University of Cambridge	Cancer Studies	Clarke A.R. Howard L.A. Harrison D.J.
Winton D.	Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine	1999	University of Cambridge	Cancer Studies	Toft N.J. Kelly J Howard L.A.
Williams PC	High-resolution field shaping utilizing a masked multileaf collimator.	2000	University of Manchester	Cancer Studies	Cooper,P
Williams PC	Customised compensation using intensity modulated beams delivered by dynamic multileaf collimation.	1999	University of Manchester	Cancer Studies	Mott,J.H.L Hounsell,A R Budgell,G J
Williams PC	Verification of dynamic mulitleaf collimation using an electronic portal imaging device	2000	University of Manchester	Cancer Studies	James,H V Atherton,S Budgell,G J
Williams PC	An experimental investigation of the tongue and groove effect for the Philips mulitleaf Collimator.	1998	University of Manchester	Cancer Studies	Sykes,J R
Williams CD	Characterisation of cell cycle status and E2F complexes in mobilized CD34+ cells before and after cytokine stimulation.	1997	University of Manchester	Cancer Studies	Linch,D.C. Watts,M.J. Thomas,N.S.
Williams CD	Purging of bone marrow in ABMT for non Hodgkin	1996	University of Manchester	Cancer Studies	Goldstone,A.H. Pearce,R.M. Philip.T.
Williams CD	p130, p107 and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alpha-interferon.	1998	University of Manchester	Cancer Studies	Thomas,NS Pizzet,AR Tiwari,S
Williams CD	Back-up bone marrow is frequently ineffective in patients with poor peripheral-blood stem-cell mobilization.	1998	University of Manchester	Cancer Studies	Watts,MJ Sullivan,AM Leverett,D
WARNER J	Daily energy expenditure and physical activity in survivors of childhood malignancy.	1998	University of Oxford	Cancer Studies	Bell, W Webb, D K H Gregory, J W
WARNER J	Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy.	1997	University of Oxford	Cancer Studies	Bell, W Webb, D K H Gregory, J W
WARNER J	Relative osteopenia after treatment for acute lymphoblastic leukemia.	1999	University of Oxford	Cancer Studies	Evans, W D Webb, D K H Bell, W
Venkitaraman A.R.	Impaired immunoglobulin gene rearrangement in mice lacking the interleukin-7 receptor.	1998	University of Cambridge	Cancer Studies	Corcoran A.E Riddell A Krooshoop D
Venkitaraman A.R.	Inhibition of interleukin-7 receptor signalling by antigen receptor assembly.	2000	University of Cambridge	Cancer Studies	Smart F.M.
Venkitaraman A.R.	Gross chromosomal rearrangements and genetic exchange between non-homologous chromosomes following BRCA2 inactivation.	2000	University of Cambridge	Cancer Studies	Yu V.PC.C. Koehler M Steinlein C
Venkitaraman A.R.	Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, BRCA2.	1999	University of Cambridge	Cancer Studies	Lee H Trainer A Friedman L.S.
Varley J	Germline mutations of TP53 in Li Fraumeni families: an extended study of 39 families.	1997	University of Manchester	Cancer Studies	McGown,G. Thorncroft,M. Santibanez-Koref,M.F.
Varley J	Identification of a novel fusion gene involving hTAFII68 and CHN from a t(9;17)(q22;q11.2) translocation in an extraskeletal myxoid chondrosarcoma.	1999	University of Manchester	Cancer Studies	Attwool,C. Tariq,M. Harris,M.
Varley J	Heterozygous germline hCHK2 mutations in Li Fraumeni Syndrome.	1999	University of Manchester	Cancer Studies	Bell,D.W. Szydlo,T.E. Kang,D.H.
Varley J	Are there low penetrance TP53 alleles? Evidence from childhood adrenocortical tumors.	1999	University of Manchester	Cancer Studies	McGown,G. Thorncroft,M James,L.A.
Valle JW	Review of recent trials of chemotherapy for advanced breast cancer: the taxanes.	1997	University of Manchester	Cancer Studies	Clemons,M Leahy,M Jayson,G
Valle JW	Pharmacokinetics of a hematopoietic peptide (SK+F 107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy	2000	University of Manchester	Cancer Studies	Zia-Amirhosseini,P Harris,RZ Cowley,HC
Valle JW	Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes.	1997	University of Manchester	Cancer Studies	Clemons,M Leahy,M Jayson,G
Valle JW	Contraceptive use in women receiving chemotherapy for breast cancer.	1998	University of Manchester	Cancer Studies	Clemons,M Hayes,S Fallowfield,L
Thatcher N	Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.	1998	University of Manchester	Cancer Studies	Vonlathen, S Heighway,J Tschan, M P
Thatcher N	Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.	1998	University of Manchester	Cancer Studies	Steward, W P Von Pawel,J Gatzemeier,U
Thatcher N	Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Lung Cancer Working P	2000	University of Manchester	Cancer Studies	Girling,D J Hopwood,P Sambrook, R J
Thatcher N	Epoietin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer.	1999	University of Manchester	Cancer Studies	De Campos, E S Bell, D R Steward, W P
Taylor-Papadimitrou J	Biology, biochemistry and immunology of carcinoma-associated mucins	1997	King's College London	Cancer Studies	Taylor-Papadimitriou, J Finn, O J
Taylor-Papadimitrou J	A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer	1999	King's College London	Cancer Studies	Lu, P J Sundquist, K Baeckstrom, D
Taylor-Papadimitrou J	Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fibrin gels	1998	King's College London	Cancer Studies	Alford, D Baeckstrom, D Geyp, M
Taylor-Papadimitrou J	Intramuscular immunisation with MUC1 cDNA can protect C57 mice challenged with MUC1-expressing syngeneis mouse tumour cells	1996	King's College London	Cancer Studies	Graham, R A Burchell, J M Beverley, P
TWYCROSS RG	Nausea and vomiting in advanced cancer	1998	University of Oxford	Cancer Studies	Back I
TWYCROSS RG	The effect of treatment choices on the total cost of palliative care	1999	University of Oxford	Cancer Studies
TWYCROSS RG	The use of low dose levomepromazine (methotrimeprazine) in the management of nausea and vomiting	1997	University of Oxford	Cancer Studies	Barkby GD Hallwood PM
TWYCROSS RG	Anorexia, cachexia, nausea and vomiting	2000	University of Oxford	Cancer Studies
TALBOT DC	Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine	2000	University of Oxford	Cancer Studies	Braybrooke JP, Vallis KA Houlbrook S
TALBOT DC	The development of a structured rating schedule (the BAS) to assess the skills in breaking bad news.	1999	University of Oxford	Cancer Studies	Miller SJ Hope T
TALBOT DC	Thymidine Phosphorylase moderates thymidine-dependent rescue after exposure to the thymidine synthase inhibitor ZD1694 (Tomudex) in vitro	1998	University of Oxford	Cancer Studies	Pattterson,AV Stratford IJ Harris AL
TALBOT DC	Evaluation of the alkaline comet assay and urine 3-methyl adenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen.	2000	University of Oxford	Cancer Studies	Braybrooke JP, Houlbrook S Crawley JE
Stern PL	Differential T helper cell responses to human papillomavirus type16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study	1998	University of Manchester	Cancer Studies	De Gruijl,T.D. Bontkes,H.J. Walboomers,J.M.
Stern PL	Integration of high risk Human Papillomavirus DNA is linked to the down-regulation of class I Human Leukocyte Antigens by steroid hormones in cervical tumour cells.	1997	University of Manchester	Cancer Studies	Bartholemew,J.S. Glenville,S. Sarkar,S
Stern PL	Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.	1997	University of Manchester	Cancer Studies	Garrido,F. Ruiz-Cabello,F. Cabrera,T.
Stern PL	Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression.	1998	University of Manchester	Cancer Studies	Bontkes,HJ Walboomers,JM Meijer,CJ
SALIO M	Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering	1997	University of Oxford	Cancer Studies	Viola A Tuosto L Linkert S
SALIO M	The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1 /KDR receptor on vascular endothelial cells	1996	University of Oxford	Cancer Studies	Albini A Soldi R Giunciuglio D
Rubens RD	Risk of complications from bone metastases in breast cancer: implications for management	2000	King's College London	Cancer Studies	Plunkett, T A Smith, P Rubens, R D
Rubens RD	Time trends in breast cancer survival: experience in a single centre, 1975-89	1998	King's College London	Cancer Studies	Bradburn, M J Altman, D G Smith, P
Rubens RD	Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer randomized phase III trial	1997	King's College London	Cancer Studies	Bartelink, H Rubens, R D van der Schueren, E
Rubens RD	Clinical course and prognostic factors following bone recurrence from breast cancer	1998	King's College London	Cancer Studies	Coleman, R E Smith, P Rubens, R D
Ranson MR	Phase I and pharmacological study of CT-2584 HMS, a modulator of phosphatidic acid adult patients with solid tumours	2000	University of Manchester	Cancer Studies	Cheeseman,S L Brannan,M McGown,A
Ranson MR	Randomised trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small cell lung cancer.	2000	University of Manchester	Cancer Studies	Davidson,N Nicolson, M Falk,S
Ranson MR	Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicentre phase II trial	1997	University of Manchester	Cancer Studies	Carmichael,J O'Byrne,K Stewart,S
Ranson MR	Phase II study of oral topotecan in advanced non-small cell lung cancer.	2000	University of Manchester	Cancer Studies	White,S C Cheeseman,S Thatcher,N
Radford JA	Further investigation of the role of HLA-DBP 1 in adult Hodgkin	1999	University of Manchester	Cancer Studies	Taylor, G M Gokhale, D A Crowther,D
Radford JA	Follow up policy after treatment for Hodgkin	1997	University of Manchester	Cancer Studies	Eardley, A Woodman, C Crowther,D
Radford JA	Assessment and significance of mediastinal bulk in Hodgkin	1999	University of Manchester	Cancer Studies	Bradley, A J Carrington, B M Lawrance, J A
Radford JA	Survival benefit from high dose therapy with autologous blood progenitor cell transplantation in poor prognosis non Hodgkin	1996	University of Manchester	Cancer Studies	Pettengell,R Morgenstern, G R Scarffe,J H
Rabbitts P.	Homozygous deletions at 3p12 in breast and lung cancer.	1998	University of Cambridge	Cancer Studies	Sundaresan V Chung G Heppell-Parton A
Rabbitts P.	Multi-step evolution of lung cancer.	1999	University of Cambridge	Cancer Studies	Braithwaite K
Rabbitts P.	A combined approach of conventional and molecular cytogenetics for detailed karyotypic analysis of the small cell lung carcinoma cell line U2020.	1999	University of Cambridge	Cancer Studies	Heppell-Parton A.C. Nacheva E Carter N.P.
Rabbitts P.	The DUTT1 gene, a novel NCAM family member, is expressed in developing murine neural tissues and has an unusually broad pattern of expression.	1998	University of Cambridge	Cancer Studies	Sundaresan V Roberts I Bateman A
REZVANI M	Repair, repopulation and cell cycle redistribution in rat foot skin	1998	University of Oxford	Cancer Studies	Robbins MEC Morris GM Hopewell JW
REZVANI M	How valid is the assumption of equal effect per fraction?	1999	University of Oxford	Cancer Studies	Ross G Morris GM Hopewell JW
REZVANI M	Time- and dose-related changes in the thickness of skin in the pig after irradiation with single doses of thulium-170 beta particles	2000	University of Oxford	Cancer Studies	Charles MW Hopewell JW Morris GM
REZVANI M	Late behavioural and neuropathological effects of local brain irradiation in the rat	1998	University of Oxford	Cancer Studies	Hodges H Katzung N Hopewell JW
Price P	Modulation of fluorouracil tissue pharmacokinetics by eniluracil: in vivo imaging of drug action.	2000	University of Manchester	Cancer Studies	Saleem,A. Yap,J. Osman,S.
Price P	Studies on the metabolism of the novel antitumour agent [N-methyl-11C]N-[2- (dimethylamino)ethyl]acridine-4-carboxamide in rats and humans prior to phase I clinical trials.	1997	University of Manchester	Cancer Studies	Osman,S. Luthra,S.K. Brady,F.
Povey AC	Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel.	2000	University of Manchester	Cancer Studies	Hall Badawi,AF Cooper,DP
Povey AC	32P-post labelling analysis of DNA adducts formed in the upper gastrointestinal tissue of mice fed bracken or bracken spores.	1996	University of Manchester	Cancer Studies	Potter,D O'Connor,PJ
Povey AC	Association between O6-alkylguanine-DNA-alkyltransferase activity in peripheral blood lymphocytes and bronchial epithelial cells.	1999	University of Manchester	Cancer Studies	O'Donnel,PN Barber,PV Margison,GP
Povey AC	Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-AT transition in the K-ras oncogene.	1997	University of Manchester	Cancer Studies	Jackson,PE Hall,CN O'Connor,PJ
Potten CS	Radiation-induced p53 and p21 WAF-1/CIP1 experssion in the murine intestine epithelium: apoptosis and cell cycle arrest.	1998	University of Manchester	Cancer Studies	Wilson, J.W. Pritchard, D.M. Hickman, J.A.
Potten CS	The relationship between ionizing radiation-induced apoptosis and stem cells in the small and large intestine.	1998	University of Manchester	Cancer Studies	Grant,H.K.
Potten CS	Damage induced apoptosis in intestinal epithelia from bcl-2 null and bax-null mice: investigations of the mechanistic determinants of epithelial apoptosis in vivo.	1999	University of Manchester	Cancer Studies	Pritchard,D.M. Korsmeyer,S.J. Roberts,S.
Potten CS	Inhibition of uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA peturbation.	1997	University of Manchester	Cancer Studies	Pritchard,D.M. Watson,A.J. Jackman,A.L.
Ponder B.A.J.	The contribution of BRCA1 to ovarian cancer	1997	University of Cambridge	Cancer Studies	Stratton J Gayther S.A. Russell P
Ponder B.A.J.	Involvement of BRCA2 in DNA repair	1998	University of Cambridge	Cancer Studies	Patel K.J. Yu V.P.C.C. Lee H
Ponder B.A.J.	A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.	2000	University of Cambridge	Cancer Studies	Healey C.S. Dunning A.M. Teare M.D.
Ponder B.A.J.	Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.	1997	University of Cambridge	Cancer Studies	Gayther S.A. Mangion J Russell P
Philpott A.	P27-Xic1, a cdk inhibitor, promotes the determination of glial cells in Xenopus retina	1999	University of Cambridge	Cancer Studies	Ohnuma S Wang K Holt C.E.
Philpott A.	Giant eyes in Xenopus laevis by overexpression of Xoptx2.	1999	University of Cambridge	Cancer Studies	Zuber M.E. Perron M Bang A
Philpott A.	Neuronal differentiation and patterning in Xenopus: the role of cdh5 and a novel activator Xp35.2.	1998	University of Cambridge	Cancer Studies	Tsai L-H Kirschner M.W.
Philpott A.	The role of cyclin-dependent kinase 5 and a novel regulatory subunit in regulating muscle differentiation and patterning	1997	University of Cambridge	Cancer Studies	Porro E.B. Kirschner M.W. Tsai L-H
Pharoah P.D.P.	Family history and the risk of breast cancer: a systematic review and meta-analysis.	1997	University of Cambridge	Cancer Studies	Day N.E. Duffy S Easton D.F.
Pharoah P.D.P.	Survival in familial, BRCA1 and BRCA2 associated epithelial ovarian cancer.	1999	University of Cambridge	Cancer Studies	Easton D.F. Stockton D.L. Gayther S.A.
Pharoah P.D.P.	Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases.	2000	University of Cambridge	Cancer Studies
Pharoah P.D.P.	Cost-effectiveness of statins in lowering cholesterol in patients with and without pre-existing coronary heart disease: life table method applied to health authority population.	1996	University of Cambridge	Cancer Studies	Hollingworth W
Peters GG	The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2	1998	King's College London	Cancer Studies	Stott, F J Bates, S James, M C
Peters GG	Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors	1997	King's College London	Cancer Studies	Hara, E Hall, M Peters, G
Peters GG	Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins	1997	King's College London	Cancer Studies	Swanton, C Mann, D J Fleckenstein, B
Peters GG	p14ARF links the tumour suppressors RB and p53	1998	King's College London	Cancer Studies	Bates, S Phillips, A C Clark, P A
Nicholson LJ	Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells	1997	King's College London	Cancer Studies	Nicholson, L J Hopwood, P Johannessen, I
Nicholson LJ	A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma	1999	King's College London	Cancer Studies	Codd, J D Salisbury, J R Packham, G
Nicholson LJ	RANTES binding and down-regulation by a novel human herpesvirus-6 b chemokine receptor	2000	King's College London	Cancer Studies	Milne, R S B Mattick, C Nicholson, L
Nicholson LJ	Role of Epstein-Barr virus gene latent membrane protein in nasopharyngeal carcinoma	1996	King's College London	Cancer Studies	Nicholson, L J Morris, J D H
Ng TT	Desensitization of the inflammatory response in humans: changes in response to cardiopulmonary bypass	1997	King's College London	Cancer Studies	Ng, T C T Gibson, F A M Nye, K E
Ng TT	PKCa regulates b1 integrin-dependent cell motility through association and control of integrin traffic	1999	King's College London	Cancer Studies	Ng, T Shima, D Squire, A
Ng TT	Imaging protein kinase Ca activation in cells	1999	King's College London	Cancer Studies	Ng, T Squire, A Hansra, G
Ng TT	The integrin-triggered rescue of T lymphocyte apoptosis is blocked in HIV-1-infected individuals	1997	King's College London	Cancer Studies	Ng, T C T Kanner, S B Humphries, M J
NORBURY CJ	Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel, highly conserved human 26S proteasome	1997	University of Oxford	Cancer Studies	Spataro, V T Toda R Craig
NORBURY CJ	Cid1: a fission yeast protein required for S-M checkpoint control when DNA polymerase d or e is inactivated	2000	University of Oxford	Cancer Studies	Wang, S-W T Toda R MacCallum
NORBURY CJ	A fission yeast homolog of Int-6,the mammalian oncoprotein and eIF3 subunit, induces drug resistance when overexpressed subunit.	2000	University of Oxford	Cancer Studies	Crane, R R Craig R Murray
NORBURY CJ	P53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells	1998	University of Oxford	Cancer Studies	Winters, Z E W M Ongkeko A L Harris
Miles DW	Breast cancer tumour vaccines	1997	King's College London	Cancer Studies	Miles, D
Miles DW	A randomized phase-II study of BB-10010 (Macrophage inflammatory protein-1a) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy	1998	King's College London	Cancer Studies	Clemons, M J Marshall, E Durig, J
Miles DW	A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer	1996	King's College London	Cancer Studies	Miles, D W Towlson, K E Graham, R
Miles DW	Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer	1999	King's College London	Cancer Studies	Houston, S J Plunkett, T A Barnes, D M
Middleton MR	Post hoc economic analysis of temozolomide versus dacarbazine in the treatment of advanced metastatic melanoma.	2000	University of Manchester	Cancer Studies	Hilner,B E Agarwala, S
Middleton MR	A randomized, phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced, metastatic malignant melanoma.	2000	University of Manchester	Cancer Studies	Grob,J J Aaronson,N Fierlbeck,G
Middleton MR	O6-methylguanine formation, repair protein depletion and clinical outcome with a 4 hr schedule of temozolomide in the treatment of advanced melanoma: results of a phase II study.	2000	University of Manchester	Cancer Studies	Lee,S M Arance,A Wood,M
Middleton MR	O6-methylguanine DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.	1999	University of Manchester	Cancer Studies	Lun,J M Morris,C Rustin,G
Margison GP	Thermostable archael O6-alkylguanine-DNA-alkyltransferases.	1998	University of Manchester	Cancer Studies	Skorvaga,M Raven, N D H
Margison GP	Induction of murine O6	1996	University of Manchester	Cancer Studies	Rafferty, J A Clarke,A R Sellappan,D
Margison GP	Long term protection of hematopoiesis against the cytotoxic effect of multiple doses of nitrosourea by retrovirus-mediated expression of human O6-alkylguanine-DNA-alkyltransferase.	1996	University of Manchester	Cancer Studies	Jelinek, J Fairburn,L J Dexter,T M
Margison GP	Targeted deletion of alkylpurine-DNA-N glycosylase in mice eliminates repair of 1,N6-ethenoadenine and hypoxanthene but not of 3,N4-ethenocytosine or 8-oxoguanine.	1997	University of Manchester	Cancer Studies	Hang, B N Singer,B Elder, R H
MORTENSEN NJM	A new look at the anal transitional zone with reference to restorative proctocolectomy and the columnar cuff	1998	University of Oxford	Cancer Studies	Thompson-Fawcett M.W. Warren B.F.
MORTENSEN NJM	Mechanisms of Inactivation of Mismatch Repair Genes in Human Colorectal Cancer Cell Lines: The Predominant Role of hMLH1	1999	University of Oxford	Cancer Studies	Wheeler J.M.D. Beck N.E. Kim H.C.
MORRIS GM	Response of the central nervous system to fractionated boron neutron capture irradiation: Studies with borocaptate sodium	1997	University of Oxford	Cancer Studies	Coderre JA Hopewell JW Rezvani M
MORRIS GM	Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine	1997	University of Oxford	Cancer Studies	Coderre J A Micca PL Hopewell JW
MORRIS GM	Boron neutron capture therapy: re-irradiation response of the rat spinal cord	1998	University of Oxford	Cancer Studies	Coderre JA Hopewell JW Micca PL
MORRIS GM	Boron microlocalisation in oral mucosal tissue: Implications for boron neutron capture therapy	2000	University of Oxford	Cancer Studies	Coderre JA Hopewell JW Rezvani M
MITCHELL C	Interphase fluorescence in situ hybridization detection of t(2;13)(q35;q14) in alveolar rhabdomyosarcoma - a diagnostic tool in minimally invasive biopsies.	1996	University of Oxford	Cancer Studies	McManus, A P OReilly, M-A J Pritchard Jones, K
MITCHELL C	Translin recognition site sequences flank chromosome translocation breakpoints in alveolar rhabdomyosarcoma cell lines.	1997	University of Oxford	Cancer Studies	Chalk, J G Barr, F G
MITCHELL C	Biologically-generated primer for PCR: PCR primer of unknown sequence.	1998	University of Oxford	Cancer Studies	Bindon, C Martindale, J
MITCHELL C	Amplification of the t(2;13) and t(1;13) translocations of alveolar rhabdomyosarcoma in small formalin-fixed biopsies using a modified reverse transcriptase polymerase chain reaction.	1997	University of Oxford	Cancer Studies	Anderson, J Renshaw, J McManus, A
Lyon M	The interaction of the transforming growth factor-s with heparin/heparan sulphate is isoform specific.	1997	University of Manchester	Cancer Studies	Rushton,G. Gallagher,J.T.
Lyon M	Elucidation of the structural features of heparan sulphate important for interaction with the Hep-2 domain of fibronectin.	2000	University of Manchester	Cancer Studies	Rushton,G. Askari,J.A. Humphries,M.J.
Lyon M	Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains.	1999	University of Manchester	Cancer Studies	Deakin,J.A.
Lyon M	Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulphate.	1998	University of Manchester	Cancer Studies	Deakin,J.A. Rahmoune,H. Fernig,D.G.
LEVITT NC	Phase II study of the oxygen saturation curve left shifting agent BW12C in combination with the hypoxia activated drug mitomycin C in advanced colorectal cancer	2000	University of Oxford	Cancer Studies	D J Popper K OByrne J P Braybrooke
LEVITT NC	Phase II study of a second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine	2000	University of Oxford	Cancer Studies	D J Popper J P Braybrooke K OByrne
LEVITT NC	Effect of Food on the Pharmacokinetics of Oral MMI270B (CGS27023A), a Novel Matrix Metalloproteinase Inhibitor	2000	University of Oxford	Cancer Studies	Ferry A L M Eskens Alex Sparreboom Les Choi
LEVITT NC	Phase 1 trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours	1999	University of Oxford	Cancer Studies	D J Propper J P Braybrooke D J Taylor
Khoo V	Comparison of 2D and 3D algorithms for adding a margin to the gross tumor volume in the conformal radiotherapy planning of prostate cancer.	1998	University of Manchester	Cancer Studies	Bedford,JL Webb,S Dearnaley,DP
Khoo V	Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.	1999	University of Manchester	Cancer Studies	Dearnealey,D Norman,AR Meyer,L
Jones NC	Herpes viral cyclin/cdk6 complexes evade inhibition by cdk inhibitor proteins.	1997	University of Manchester	Cancer Studies	Swanton, C. Mann, D.J. Fleckenstein, B.
Jones NC	Regulation of the fission yeast transcription factor Pap1 by oxidative stress: requirements for the nuclear export factor Crm1 (Exportin) and the stress-activated MAP kinase Sty1/Spc 1	1998	University of Manchester	Cancer Studies	Toone,W.M. Kuge,S. Samuels,M.
Jones NC	Cell cycle regulated transcription in fission yeast: cdc 10-Res protein interactions during the cell cycle and domains required for regulated transcription.	1999	University of Manchester	Cancer Studies	Whitehall,S. Stacey,P. Dawson,K.
Jones NC	The Aft1 transcription factor is a target for the Sty1 stress activated MAP kinase pathway in fission yeast.	1996	University of Manchester	Cancer Studies	Wilkinson, M.G. Samuels, M. Takeda,T.
Jayson GC	Heparin oligosaccharides: Inhibitors of the biological activity of bFGF on Caco-2 cells.	1997	University of Manchester	Cancer Studies	Gallagher,J T
Jayson GC	Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma.	1999	University of Manchester	Cancer Studies	Vives,C Paraskeva,C Schofield,K
Jayson GC	Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro.	1998	University of Manchester	Cancer Studies	Lyon,M Paraskeva,C Turnbull,J E
Jayson GC	An audit of primary surgical treatment for women with ovarian cancer referred to a cancer centre.	1999	University of Manchester	Cancer Studies	Sengupta,P S Slade, R J Eardley,A
ILYAS M	The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's two hit hypothesis	1999	University of Oxford	Cancer Studies	Lamlum, H Rowan, A Clark, S
ILYAS M	b-catenin mutations in cell lines established from human colorectal cancers	1997	University of Oxford	Cancer Studies	Tomlinson, IPM Rowan, A Pignatelli, M
ILYAS M	APC mutations in sporadic colorectal tumours: A mutational hotspot and interdependence of the two hits	2000	University of Oxford	Cancer Studies	Rowan, AJ Lamlum, H Wheller, J
ILYAS M	Transforming growth factor beta stimulation of colorectal cell lines: Type II receptor bypass and changes in adhesion molecule expression	1999	University of Oxford	Cancer Studies	Efstathiou, JA Straub, J Kim, HC
IKEMIZU S	Crystal structure and functional dissection of the cytostatic cytokine Oncostatin M	2000	University of Oxford	Cancer Studies	Deller MC Jones EY Heath JK
IKEMIZU S	Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8 resolution	1999	University of Oxford	Cancer Studies	Stuart DI Jones EY Davis SJ
IKEMIZU S	Structural basis of cell-cell adhesion by NCAM	2000	University of Oxford	Cancer Studies	Kasper C Rasmussen H Kastrup JS
Howell A	Recent advances in endocrine therapy of breast cancer	1997	University of Manchester	Cancer Studies	Dowsett,M
Howell A	ICI 182,780 (Faslodex): development of a novel, pure antiestrogen	2000	University of Manchester	Cancer Studies	Osborne,C.K. Morris,C. Wakeling,A.E.
Howell A	Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group	1996	University of Manchester	Cancer Studies	Buzdar,A Jonat,W Jones,S.E.
Howell A	Pharmacokinteics, systemic and antitumour effects of the specific antiestrogen ICI 182780 in women with advanced breast cancer	1996	University of Manchester	Cancer Studies	Defriend,D. Robertson,J.F.R. Blamey,R.
Hendry JH	Loss of atm radiosensitises multiple p53-null tissues.	1998	University of Manchester	Cancer Studies	Westphal,C.H. Hoyes,K.P. Canman,C.E.
Hendry JH	Development of synthetic promoters for radiation-mediated gene therapy.	2000	University of Manchester	Cancer Studies	Marples,B Scott,S.D. Embleton,M.J.
Hendry JH	p-53 deficiency sensitizes clonogenic cells to irradiation in the large but not the small intestine.	1997	University of Manchester	Cancer Studies	Cai,W.B. Roberts, S.A. Potten,C.
Hendry JH	Differential influence of TGFbeta1 and TGFbeta3 isoforms on cell cycle kinetics and post-irradiation recovery of normal and malignant colorectal epithelial cells.	1997	University of Manchester	Cancer Studies	Robson,H. Spence,K Anderson,E.
Hawkins RE	Selective targeting of gene transfer to vascular endothelial cells using peptide isolated by phage display.	2000	University of Manchester	Cancer Studies	Nicklin,S.A. White,S.J. Watkins,S.J.
Hawkins RE	Pharmacological control of antigen responsiveness in genetically modified T lymphocytes.	1997	University of Manchester	Cancer Studies	Alvarez-Vallina,L. Agha-Mohammadi,S. Russel,S.J.
Hawkins RE	Antigen specific targeting of CD28-mediated T cell costimulation using chimeric scFv-CD28 receptors.	1996	University of Manchester	Cancer Studies	Alvarez-Vallina,L.
Hawkins RE	The adenobody approach to viral targeting: specific and enhanced adenoviral gene delivery.	1997	University of Manchester	Cancer Studies	Watkins,S.J. Mesyanzhinov,V.V. Korochkina,L.P.
Hart IR	Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression	1996	King's College London	Cancer Studies	Francia, G Mitchell, S D Moss, S E
Hart IR	Identification by differential display of a protein phosphatase-2A regulatory subunit preferentially expressed in malignant melanoma cells	1999	King's College London	Cancer Studies	Francia, G Poulsom, R Hanby, A M
Hart IR	The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments	1999	King's College London	Cancer Studies	Assmann, V Jenkinson, D Marshall, J F
Hart IR	Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells	1997	King's College London	Cancer Studies	Ahmad, A Marshall, J F Basset, P
HOPEWELL JW	Volume effects in radiobiology as applied to radiotherapy	2000	University of Oxford	Cancer Studies	Trott K-R
HOPEWELL JW	Radiation injury to the central nervous system	1998	University of Oxford	Cancer Studies
HOPEWELL JW	The pig as a model for the study of radiation effects on the lung	2000	University of Oxford	Cancer Studies	Rezvani M Moustafa HF
HOPEWELL JW	Long-term changes in irradiated tissues are due principally to vascular damage in the tissues	1998	University of Oxford	Cancer Studies	Withers HR
HICKSON ID	Cloning and characterization of a functional human homolog of E. coli endonuclease III.	1997	University of Oxford	Cancer Studies	Aspinwall R Rothwell D.G Roldan-Arjona T
HICKSON ID	The Blooms syndrome gene product is a 3-5 DNA helicase.	1997	University of Oxford	Cancer Studies	Karow, J.K. Chakraverty, R.K.
HICKSON ID	Oligomeric ring structure of the Blooms syndrome helicase.	1999	University of Oxford	Cancer Studies	Karow, J.K. Newman, R.H. Freemont, P.S.
HICKSON ID	The Blooms syndrome gene product promotes branch migration of Holliday junctions	2000	University of Oxford	Cancer Studies	Karow, K.J. Constantinou, A Li, J-Y
HARRIS AL	Expression of the angiogenic factors vascular endothelial-cell growth-factor, acidic and basic fibroblast growth-factor, tumor-growth factor-beta-1, platelet-derived endothelial-cell growth factor, placenta growth factor, and pleiotrophin in human primary	1997	University of Oxford	Cancer Studies	Relf,M Lejeune, S. Scott, P.A.E
HARRIS AL	Targeting gene expression to hypoxic tumour cells	1997	University of Oxford	Cancer Studies	Dachs, G.U Patterson, A.V., Firth, J.D
HARRIS AL	Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients.	1997	University of Oxford	Cancer Studies	Fox,S.B Leek, R.D Bliss, J
HARRIS AL	The expression and distribution of the hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in normal human tissues, cancers and tumor-associated macrophages.	2000	University of Oxford	Cancer Studies	Talks,K.L Turley, H Gatter, K.C
Gherardi E.	The effect of high-frequency mutagenesis on in vitro protein evolution. A study on the enzyme TEM-1 b-lactamase.	1999	University of Cambridge	Cancer Studies	Zaccolo M
Gherardi E.	Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans and improved activity in vivo	1998	University of Cambridge	Cancer Studies	Hartmann G Prospero T Brinkmann V
Gherardi E.	An approach to mutagenesis with deoxynucleotide triphosphate analogues.	1996	University of Cambridge	Cancer Studies	Zaccolo M Williams D Brown D
Gherardi E.	Crystal structure of a receptor-binding fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding	1999	University of Cambridge	Cancer Studies	Chirgadze D Hepple J Zhou H
George NJ	Growth inhibition of prostate cell lines in vitro by phyto-oestrogens.	1998	University of Manchester	Cancer Studies	Hempstock,J Kavanagh,JP
George NJ	Paradoxical expression of E. cadherin in prostatic bone metastasis.	1999	University of Manchester	Cancer Studies	Bryden,AA Freemont,AJ Clarke,NW
George NJ	Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro.	1999	University of Manchester	Cancer Studies	Lang,SH Clarke,NW Testa,NG
George NJ	Optimization of Reverse Transcriptase Polymerase Chain Reaction for the detection of circulating prostate cells.	2000	University of Manchester	Cancer Studies	McIntyre,IG Spreckley,K Clarke,RB
Gallagher JT	A strategy for rapid sequencing of heparan sulfate and heparin saccharides.	1999	University of Manchester	Cancer Studies	Turnbull,J.E. Hopwood,J.J.
Gallagher JT	Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation.	1999	University of Manchester	Cancer Studies	Pye,D.A
Gallagher JT	The effect of alpha-4-beta-1-integrin binding sequences of fibronectin on growth of cells from human haematopoietic progenitors.	1998	University of Manchester	Cancer Studies	Schofield,K.P. Humphries,M.J. De Wynter,E.
Gallagher JT	Highly sensitive sequencing of the sulphated domains of heparan sulphate.	1999	University of Manchester	Cancer Studies	Merry,C.L. Lyon,M. Deakin,J.A.
GLEADLE JM	Hypoxia inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth	1997	University of Oxford	Cancer Studies	Maxwell PH Dachs GU Ratcliffe PJ
GANESAN TS	Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer	1996	University of Oxford	Cancer Studies	Cooke,I. E. Shelling, A. N. Le Meuth, V. G
GANESAN TS	Functional analysis of H-Ryk, an atypical member of the receptor tyrosine kinase family.	1999	University of Oxford	Cancer Studies	Katso, R.M Russell, R. B
GANESAN TS	Overexpression of H-Ryk in epithelial ovarian cancer: prognostic significance of receptor expression	2000	University of Oxford	Cancer Studies	Katso, R. M Manek, S Ganjavi, H
GANESAN TS	Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer	1999	University of Oxford	Cancer Studies	Katso, R. M Manek,S
Fentiman IS	Body weight and vascular invasion in post-menopausal women with breast cancer	1997	King's College London	Cancer Studies	Badwe, R A Fentiman, I S Millis, R R
Fentiman IS	Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results on the EORTC randomised phase III trial 10853	2000	King's College London	Cancer Studies	Julien, J Bijker, N Fentiman, I S
Fentiman IS	Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumour	1999	King's College London	Cancer Studies	Cooper, L S Gillett, C E Patel, N K
Fentiman IS	Electropotential measurements as a new diagnostic modality for breast cancer	1998	King's College London	Cancer Studies	Cuzick, J Holland, R Barth, V
Fairbairn L	O6-Benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow.	1997	University of Manchester	Cancer Studies	Chinnasamy,N. Rafferty,J.A. Hickson,I.
Fairbairn L	Chemoprotective gene transfer II: multilineage, in vivo protection of haemopoiesis against the effects of an anti-tumour agent by expression of a mutant human O6-Alkylguanine-DNA Alkyltransferase.	1998	University of Manchester	Cancer Studies	Chinnasamy,N. Rafferty,J.A. Hickson,I.
Fairbairn L	Recombinant adenoassociated virus mediated expression of O6-Alkylguanine-DNA Alkyltransferase protects human epithelial and haemopoietic cells against chloroethylating agent toxicity.	1999	University of Manchester	Cancer Studies	Longhurst,S.J. Rafferty,J.A. Arrand,J
Fairbairn L	Long term in vitro correction of alpha-L-iduronidase deficiency (Hurler Syndrome) in human bone marrow.	1996	University of Manchester	Cancer Studies	Lashford,L.J. Spooncer,C. McDermott,R.H.
Earl H.M.	Chemotherapy for ovarian cancer - a consensus statement on standard practice	1998	University of Cambridge	Cancer Studies	Adams M A'Hern R.P. Calvert A.H.
Earl H.M.	Psychological predictors of attendance at annual breast screening examinations	1998	University of Cambridge	Cancer Studies	Burton MV Warren R Price D
Earl H.M.	Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cis with previously untreated advanced epithelial ovarian cancer.	2000	University of Cambridge	Cancer Studies	Poole C.J. Perren T Burton A
Earl H.M.	Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.	1996	University of Cambridge	Cancer Studies	Baker P Kerr D.J. Lee M
Dey MP	Adequacy of cervical Cytological sampling with the Cervex brush and the Aylesbury spatula: a population based randomised controlled trial.	1996	University of Manchester	Cancer Studies	Collins,S Desai,M Woodman,C
Dey MP	A population based survey of the management of women with cancer of the cervix.	1999	University of Manchester	Cancer Studies	Clarke,F Collins,S
Dey MP	Completeness of reporting on prognostic factors for breast cancer: a regional survey.	1997	University of Manchester	Cancer Studies	Woodman,C B Gibbs,A Coyne,J
Dey MP	Should smoking cessation cost a packet? A pilot randomised controlled trial of the cost effectiveness of distributing nicotine therapy free of charge.	1999	University of Manchester	Cancer Studies	Foy,R Woodman,M Fullard,B
Dermime S	Lack of T-cell mediated recognition of the fusion region of the pml/RAR-alpha hybrid protein by lymphocytes of acute promyelocytic leukaemia patients.	1996	University of Manchester	Cancer Studies	Bertazzoli, C Marchesi,E Ravagnani,F
Dermime S	Alloreactive CD4+ T lymphocytes exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigen.	1996	University of Manchester	Cancer Studies	Jiang,YZ Mavroudis,D Hensel,N
Dermime S	Targeted T-cell therapy for human leukaemia: Cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukaemia cells.	1996	University of Manchester	Cancer Studies	Molldrem,J Parker,K Jiang,YZ
Dermime S	Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus leukaemia reaction.	1998	University of Manchester	Cancer Studies	Mavroudis,DA Molldrem,J Jiang,YZ
DUNBAR PR	A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response	2000	University of Oxford	Cancer Studies	Smith CL Harris AL Cerundolo
DUNBAR PR	Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent	1999	University of Oxford	Cancer Studies	Whelan JA Price DA Sewell AK
DUNBAR PR	Direct isolation, phenotyping, and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood	1998	University of Oxford	Cancer Studies	Ogg GS Chen J Cerundolo V
DUNBAR PR	Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma	1999	University of Oxford	Cancer Studies	Chen J-L Chao D Cerundolo V
Chopra R	Campath 1H prevents Graft versus Host Disease following non-myeloablative stem cell transplantation.	2000	University of Manchester	Cancer Studies	Kottarides,P. Milligan,D. Chakraverty,R.K.
Chopra R	Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).	2000	University of Manchester	Cancer Studies	Champlin,R.E. Schmitz,N. Horovitz,M.M.
Chopra R	Expression of two alternatively spliced form of the 5	1996	University of Manchester	Cancer Studies	Kendall,G. Gale,R.E. Thomas,N.S.B.
Chopra R	Dynamics of Telomere shortening in Neutrophils and T-lymphocytes during ageing and relationship to acquired skewing of X-chromosome inactivation patterns.	2000	University of Manchester	Cancer Studies	Robertson,J. Gale,R.E. Wynn,R.
Camplejohn RS	Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni like family members	1998	King's College London	Cancer Studies	Lomax, M E Barnes, D M Hupp, T R
Camplejohn RS	Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family	1998	King's College London	Cancer Studies	Varley, J M Chapman, P McGown, G
Camplejohn RS	Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression	1997	King's College London	Cancer Studies	Vile, R G Castleden, S Marshall, J
Camplejohn RS	Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family	1997	King's College London	Cancer Studies	Lomax, M E Barnes, D M Gilchrist, R
Caldas C.M.D.S.	Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.	1997	University of Cambridge	Cancer Studies	Gayther S.A. Barski P Batley S.J.
Caldas C.M.D.S.	Identification of germline E-cadherin mutations in gastric cancer families of European origin.	1998	University of Cambridge	Cancer Studies	Gayther S.A. Gorringe K.L. Ramus S
Caldas C.M.D.S.	MLL2, the second human homolog of the Drosophila trithorax gene, maps to 19q13.1 and is amplified in solid tumor cell lines	1999	University of Cambridge	Cancer Studies	Huntsman D.G. Chin S-F Muleris M
Caldas C.M.D.S.	Mutations truncating the EP300 acetylase in human cancers.	2000	University of Cambridge	Cancer Studies	Gayther S.A. Batley S.J. Linger L
CERUNDOLO V	Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes	1998	University of Oxford	Cancer Studies	Romero, P Dunbar, P R Ogg GS
CERUNDOLO V	High frequency of skin-homin melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo	1998	University of Oxford	Cancer Studies	Ogg, G S Dunbar, P R Chen J-L
CERUNDOLO V	Association of a syndrome resembling Wegeners granulomatosis with low surface expression of HLA class I molecules	1999	University of Oxford	Cancer Studies	Moins-Teisserenc, H T Gadola, S Dunbar PR
CERUNDOLO V	Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor reactive cytotoxic T lymphocytes	2000	University of Oxford	Cancer Studies	Chen, J Dunbar, R Gileadi, U
Byrne GJ	Serum soluble vascular cell adhesion molecule 1: Role as a surrogate marker of angiogenesis.	2000	University of Manchester	Cancer Studies	Ghellal,A. Iddon,J. Blann,A.D.
Byrne GJ	Improving uptake of prophylaxis for venous thromboembolism in general surgical patients using prospective audit.	1996	University of Manchester	Cancer Studies	McCarthy,M. Silverman,D.H.
Byrne GJ	Breast carcinoma vascular density determined using CD105 antibody correlates with tumour prognosis.	1999	University of Manchester	Cancer Studies	Kumar,S. Ghellal,A. Li,C.
Byrne GJ	Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer.	2000	University of Manchester	Cancer Studies	Li, C. Guo,B. Wilson,P.B.
Burnet N.G.	Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities	2000	University of Cambridge	Cancer Studies	Carlomagno F Turesson I Nyman J
Burnet N.G.	Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy.	1996	University of Cambridge	Cancer Studies	Wurm R Peacock J.H.
Burnet N.G.	Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity.	1998	University of Cambridge	Cancer Studies	Johansen J Turesson I Nyman J
Burnet N.G.	Improving cancer outcomes through radiotherapy. Lack of UK radiotherapy resources prejudices cancer outcomes.	2000	University of Cambridge	Cancer Studies	Benson R.J. Williams M.V Peacock J.H.
Burchell J	Expression of B7.1 in an MUC1-expressing mouse mammary epithelial tumour cell line inhibits tumorigenicity but does not induce autoimmunity in MUC1 transgenic mice	1999	King's College London	Cancer Studies	Smith, M Burchell, J M Graham, R
Burchell J	Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines: demonstration of simpler and fewer glycan chains in tumor cells	1996	King's College London	Cancer Studies	Lloyd, K O Burchell, J Kudryashov, V
Burchell J	A transfected sialytransferase that is elevated in brast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-Glycans	1997	King's College London	Cancer Studies	Whitehouse, C Burchell, J Gschmeissner, S
Burchell J	An a2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinoma	1999	King's College London	Cancer Studies	Burchell, J Poulsom, R Hanby, A
Bundred NJ	Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast.	1997	University of Manchester	Cancer Studies	Holland,P.A. Knox,W.F. Potten,C.S
Bundred NJ	Effects of a pure antioestrogen on apoptosis and proliferation within human breast ductal carcinoma in situ.	2000	University of Manchester	Cancer Studies	Ghandi,A. Holland,P. Knox,W.F.
Bundred NJ	Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit.	1996	University of Manchester	Cancer Studies	Harding,C. Knox,W.F. Farager,E.B.
Bundred NJ	Randomised controlled trial of effects of early discharge after surgery for breast cancer.	1998	University of Manchester	Cancer Studies	Maguire,P. Reynolds,J Grimshaw,J
Brenton J.D.	Imprinting and gene silencing in mice and Drosophila.	1998	University of Cambridge	Cancer Studies	Ainscough J.F. Lyko F Paro R
Brenton J.D.	An imprinting element from the mouse H19 locus functions as a silencer in Drosophila.	1997	University of Cambridge	Cancer Studies	Lyko F Surani M.A. Paro R
Brenton J.D.	Deletion of a silencer element disrupts H19 imprinting independently of a DNA methylation epigenetic switch.	2000	University of Cambridge	Cancer Studies	Drewell R.A. Ainscough J.F. Barton S.C.
Brenton J.D.	A silencer element identified in Drosophila is required for imprinting of H19 reporter transgenes in mice.	1999	University of Cambridge	Cancer Studies	Drewell R.A. Viville S Hilton K.J.
Barnes DM	Expression of c-erbB2 and p53 protein is similar in breast cancer from British and Japanese women	1999	King's College London	Cancer Studies	Merchant, W J Millis, R R Smith, P
Barnes DM	Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer	1997	King's College London	Cancer Studies	Steiner, P Barnes, D M Harris, W H
Barnes DM	Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer	1999	King's College London	Cancer Studies	Roylance, R Gorman, P Harris, W
Barnes DM	Response of metastatic breast cancer to trastuzumab?	2000	King's College London	Cancer Studies	Barnes, D M Miles, D W
BODMER W	The somatic evolution of cancer. The Harveian Oration of 1996	1996	University of Oxford	Cancer Studies
BODMER W	The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudsons two-hit hypothesis.	1999	University of Oxford	Cancer Studies	Lamlum, H Ilyas, M. Rowan, A
BODMER W	The APC variants I1307K and E1317Q are associated with colorectal tumours, but not always with a family history.	1998	University of Oxford	Cancer Studies	Frayling, I.M. Beck, N. Ilyas, M.
BODMER W	b-catenin mutations in cell lines established from human colorectal cancers	1997	University of Oxford	Cancer Studies	Ilyas, M. Tomlinson,I.P.M. Rowan, A.
BICKNELL R	Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.	1997	University of Oxford	Cancer Studies	Ziche, M. Morbidelli,L Choudhuri, R
BICKNELL R	An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis.	1997	University of Oxford	Cancer Studies	Choudhuri, R., Zhang, H. T Donnini, S
BICKNELL R	Endothelial cell-specific expression of tumor necrosis factor-alpha from the KDR or E-selectin promoters following retroviral delivery	1997	University of Oxford	Cancer Studies	Jaggar, R. T Chan, H. Y Harris, A. L.
BICKNELL R	Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor	2000	University of Oxford	Cancer Studies	Fraser, H. M Dickson, S. E Lunn, S.F.
Aparicio S.A.J.R.	Eomesodermin is required for mouse trophoblast development and mesoderm formation	2000	University of Cambridge	Cancer Studies	Russ A.P. Wattler S Colledge W.H
Aparicio S.A.J.R.	Regulation of maternal behaviour and offspring growth by paternally expressed Peg3	1999	University of Cambridge	Cancer Studies	Li L Keverne E.B. Ishino F
Aparicio S.A.J.R.	How to count human genes	2000	University of Cambridge	Cancer Studies
Aparicio S.A.J.R.	Organization of the Fugu rubripes Hox clusters: evidence for continuing evolution of vertebrate Hox complexes	1997	University of Cambridge	Cancer Studies	Hawker K Cottage A Mikawa Y
Anderson NG	Wortmannin sensitive activation of p70s6k by endogenous and heterologously expressed Gi coupled receptors.	1996	University of Manchester	Cancer Studies	Wilson,M. Burt,A.R. Milligan,G.
Anderson NG	Mitogenic signalling by delta opioid receptors expressed in Rat-1 fibroblasts involves activation of p70s6k/p85s6k S6 kinase.	1997	University of Manchester	Cancer Studies	Wilson,M. Burt,A.R. Milligan,G.
Anderson NG	Growth hormone-dependent differentiation of 3T3-F442A preadipocytes requires the Janus kinase/signal transducer and activator of transcription but not mitogen activated protein kinase or p70- S6 kinase signalling.	1999	University of Manchester	Cancer Studies	Yarwood,S.J. Sale,E.M. Sale,G.J.
Anderson NG	Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the MAP kinase and p70s6k pathways.	1996	University of Manchester	Cancer Studies	Kilgour,E. Gout,I.
Allen T	The nuclear pore complex and lamina: three dimensional structures and interactions determined by field emission in-lens scanning electron microscopy.	1996	University of Manchester	Cancer Studies	Goldberg, M
Allen T	The Nuclear pore complex.	2000	University of Manchester	Cancer Studies	Bagley, S Goldberg, M.W. Cronshaw, J.M.
Allen T	RNP export is mediated by structural reorganization of the nuclear pore basket.	1996	University of Manchester	Cancer Studies	Kiseleva, E Goldberg, M.W. Daneholt, B
Allen T	Nuclear envelope and nuclear pore assembly: analysis of assembly intermediates by electron microscopy.	1998	University of Manchester	Cancer Studies	Gant, T.M. Goldberg, M.W.
Sutton R	Determining the optimal pacing intervention rate for vasovagal syncope	2000	Imperial College of Science, Technology	Cardio - Arrhythmias	Kurbaan AS Franzen AC Heaven D
Sutton R	The normal response to prolonged passive head up tilt testing	2000	Imperial College of Science, Technology	Cardio - Arrhythmias	Petersen MEV Williams TR Gordon C
Sutton R	Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two-stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin	1999	Imperial College of Science, Technology	Cardio - Arrhythmias	Kurbaan AS Bowker TJ Kaddoura S
Sutton R	Cardioinhibition during tilt testing identifies patients who may benefit from pacing	2000	Imperial College of Science, Technology	Cardio - Arrhythmias	Kurbaan AS Franzen AC Heaven D
Peters N S	Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia	1999	Imperial College of Science, Technology	Cardio - Arrhythmias	Schilling RJ Davies DW
Peters N S	Simultaneous endocardial mapping in the human left ventricle using a noncontact catheter - Comparison of contact and reconstructed electrograms during sinus rhythm	1998	Imperial College of Science, Technology	Cardio - Arrhythmias	Schilling RJ Davies W
Peters N S	Characteristics of the temporal and spatial excitable gap in anisotropic reentrant circuits causing sustained ventricular tachycardia	1998	Imperial College of Science, Technology	Cardio - Arrhythmias	Coromilas J Hanna MS Josephson ME
Peters N S	Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia	1997	Imperial College of Science, Technology	Cardio - Arrhythmias	Coromilas J Severs NJ Wit AL
Ho S Y	Angiographic anatomy of the inferior right atrial isthmus in patients with and without history of common atrial flutter	1999	Imperial College of Science, Technology	Cardio - Arrhythmias	Cabrera JA Sanchez-Quintana D Anderson RH
Ho S Y	Clinical anatomy of the normal pulmonary root compared with that in isolated pulmonary valvular stenosis	1998	Imperial College of Science, Technology	Cardio - Arrhythmias	Stamm C Anderson RH
Ho S Y	Fibrous matrix of ventricular myocardium in tricuspid atresia compared with normal heart - A quantitative analysis	1996	Imperial College of Science, Technology	Cardio - Arrhythmias	Jackson M Smith A Gerlis LM
Ho S Y	Anisotropic conduction in the triangle of Koch of mammalian hearts: Electrophysiologic and anatomic correlations	1998	Imperial College of Science, Technology	Cardio - Arrhythmias	Hocini M Loh P De Bakker JMT
Gatzoulis M A	Atrial arrhythmia after surgical closure of atrial septal defects in adults	1999	Imperial College of Science, Technology	Cardio - Arrhythmias	Siu SC Webb GD Harris L
Gatzoulis M A	Right and left ventricular systolic function late after repair of tetralogy of fallot	2000	Imperial College of Science, Technology	Cardio - Arrhythmias	Elliott JT Siu SC Webb GD
Gatzoulis M A	Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study	2000	Imperial College of Science, Technology	Cardio - Arrhythmias	Poile C Rosenthal M Redington AN
Gatzoulis M A	Depolarization-repolarization inhomogeneity after repair of tetralogy of Fallot - The substrate for malignant ventricular tachycardia?	1997	Imperial College of Science, Technology	Cardio - Arrhythmias	Till JA Redington AN
Davies D W	Human left ventricular endocardial activation mapping using a novel noncontact catheter	1997	Imperial College of Science, Technology	Cardio - Arrhythmias	Peters NS Jackman WM Schilling RJ
Davies D W	Mapping and ablation of ventricular tachycardia with the aid of a non-contact mapping system	1999	Imperial College of Science, Technology	Cardio - Arrhythmias	Schilling RJ Peters NS
Davies D W	Endocardial mapping of atrial fibrillation in the human right atrium using a non-contact catheter	2000	Imperial College of Science, Technology